SRPK3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P31751 | S474 | Sugiyama | AKT2 | DRyDsLGLLELDQRTHFPQFsysAsIRE_____________ |
| P31751 | S478 | Sugiyama | AKT2 | sLGLLELDQRTHFPQFsysAsIRE_________________ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P46108 | Y47 | Sugiyama | CRK | LQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYIINSSGP |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | S603 | Sugiyama | FXR2 FMR1L2 | QRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsR |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q13371 | S25 | Sugiyama | PDCL PHLOP1 PhLP1 | DDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPAsssVPAE |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q8IYB3 | S402 | Sugiyama | SRRM1 SRM160 | PRKTRRLsPsAsPPRRRHRPsPPAtPPPKtRHsPtPQQsNR |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96JP5 | S85 | Sugiyama | ZFP91 ZNF757 FKSG11 | AAAVSRRRKAEYPRRRRssPsARPPDVPGQQPQAAKsPsPV |
| Q96MU7 | S308 | Sugiyama | YTHDC1 KIAA1966 YT521 | GSGTDGsDEKKKERKRARGIsPIVFDRsGssAsESYAGsEK |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NYV4 | S249 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | DSSKQDDsPsGAsYGQDyDLsPsRsHtssNYDsYKKsPGsT |
| Q9UPE1 | Y116 | Sugiyama | SRPK3 MSSK1 STK23 | CWDIQRKRFVALKVVKSAGHyTETAVDEIKLLKCVRDSDPS |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQ35 | S1102 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | EsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFs |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | T328 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APFsEPGttstQRPssPEtAtKQPssPYEDKDKDKKEKsAt |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.111093e-09 | 8.675 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.629978e-08 | 7.580 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.411846e-08 | 7.467 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.502283e-07 | 6.823 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.835290e-07 | 6.547 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.470028e-07 | 6.262 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.522464e-07 | 6.021 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.435452e-06 | 5.843 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.618905e-06 | 5.791 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.077055e-05 | 4.968 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.624122e-05 | 4.789 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.450531e-05 | 4.838 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.478970e-05 | 4.830 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.570649e-05 | 4.804 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.590701e-05 | 4.798 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.616406e-05 | 4.442 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.798692e-05 | 4.420 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.207489e-05 | 4.376 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.490165e-05 | 4.348 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.371723e-05 | 4.077 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.663211e-04 | 3.779 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.038945e-04 | 3.691 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.201037e-04 | 3.657 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.393757e-04 | 3.621 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.293253e-04 | 3.482 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.513256e-04 | 3.454 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.513256e-04 | 3.454 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.128692e-04 | 3.384 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.940804e-04 | 3.306 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.942533e-04 | 3.306 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.564396e-04 | 3.183 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.868152e-04 | 3.163 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.774064e-04 | 3.057 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.053925e-04 | 3.043 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.261811e-04 | 3.033 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.670927e-04 | 3.015 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.846661e-04 | 3.007 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.165750e-03 | 2.933 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.359368e-03 | 2.867 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.407461e-03 | 2.852 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.401394e-03 | 2.853 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.567429e-03 | 2.805 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.319778e-03 | 2.635 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.319778e-03 | 2.635 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.210168e-03 | 2.656 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.117840e-03 | 2.674 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.062164e-03 | 2.686 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.173290e-03 | 2.663 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.319778e-03 | 2.635 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.288626e-03 | 2.640 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.571895e-03 | 2.590 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.680327e-03 | 2.572 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.980604e-03 | 2.526 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.888797e-03 | 2.539 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.778939e-03 | 2.556 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.850494e-03 | 2.545 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.002500e-03 | 2.523 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.150991e-03 | 2.502 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.206792e-03 | 2.494 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.430737e-03 | 2.465 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.688224e-03 | 2.433 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.827328e-03 | 2.417 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.706449e-03 | 2.431 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.706449e-03 | 2.431 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.891335e-03 | 2.410 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.899990e-03 | 2.409 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.221936e-03 | 2.374 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.421204e-03 | 2.354 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.537575e-03 | 2.343 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.975948e-03 | 2.303 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.814902e-03 | 2.317 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.976750e-03 | 2.303 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.985252e-03 | 2.302 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.999511e-03 | 2.301 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.760676e-03 | 2.240 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.068296e-03 | 2.217 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.515193e-03 | 2.186 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.490455e-03 | 2.188 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.751394e-03 | 2.171 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.187879e-03 | 2.143 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.972168e-03 | 2.157 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.010727e-03 | 2.154 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.004747e-03 | 2.155 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.547307e-03 | 2.122 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.686251e-03 | 2.114 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.237718e-03 | 2.084 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.539136e-03 | 2.069 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 9.273858e-03 | 2.033 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.564317e-03 | 2.019 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.170942e-03 | 2.038 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.634077e-03 | 2.016 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.010802e-02 | 1.995 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.154245e-02 | 1.938 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.144483e-02 | 1.941 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.144483e-02 | 1.941 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.144483e-02 | 1.941 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.097897e-02 | 1.959 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.097897e-02 | 1.959 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.177033e-02 | 1.929 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.179272e-02 | 1.928 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.193883e-02 | 1.923 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.193883e-02 | 1.923 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.203060e-02 | 1.920 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.203060e-02 | 1.920 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.323495e-02 | 1.878 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.323495e-02 | 1.878 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.251983e-02 | 1.902 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.347403e-02 | 1.871 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.347403e-02 | 1.871 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.383816e-02 | 1.859 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.421677e-02 | 1.847 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.447280e-02 | 1.839 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.474702e-02 | 1.831 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.494053e-02 | 1.826 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.510686e-02 | 1.821 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.668682e-02 | 1.778 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.797994e-02 | 1.745 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.862144e-02 | 1.730 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.862144e-02 | 1.730 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.914211e-02 | 1.718 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.946070e-02 | 1.711 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.967825e-02 | 1.706 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.967825e-02 | 1.706 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.007782e-02 | 1.697 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.007782e-02 | 1.697 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.020307e-02 | 1.695 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.073046e-02 | 1.683 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.274115e-02 | 1.643 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.121597e-02 | 1.673 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.309764e-02 | 1.636 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.379987e-02 | 1.623 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.418879e-02 | 1.616 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.481687e-02 | 1.605 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.513923e-02 | 1.600 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.573244e-02 | 1.590 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.599700e-02 | 1.585 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.756735e-02 | 1.560 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.960551e-02 | 1.529 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.960551e-02 | 1.529 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.960551e-02 | 1.529 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.996261e-02 | 1.523 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.989991e-02 | 1.524 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.979601e-02 | 1.526 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.181881e-02 | 1.497 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.295850e-02 | 1.482 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.295850e-02 | 1.482 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.295850e-02 | 1.482 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.297865e-02 | 1.482 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.344655e-02 | 1.476 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.427160e-02 | 1.465 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.446065e-02 | 1.463 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.550670e-02 | 1.450 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.550891e-02 | 1.450 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.937523e-02 | 1.405 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.949938e-02 | 1.403 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.949938e-02 | 1.403 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.575155e-02 | 1.447 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.759213e-02 | 1.425 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.937523e-02 | 1.405 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.570117e-02 | 1.447 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.949938e-02 | 1.403 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.970138e-02 | 1.401 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.970138e-02 | 1.401 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.970138e-02 | 1.401 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.970138e-02 | 1.401 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.970138e-02 | 1.401 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.980744e-02 | 1.400 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.029230e-02 | 1.395 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.159668e-02 | 1.381 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.230720e-02 | 1.374 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 4.748130e-02 | 1.323 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 4.748130e-02 | 1.323 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.817932e-02 | 1.317 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.817932e-02 | 1.317 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.817932e-02 | 1.317 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.817932e-02 | 1.317 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.817932e-02 | 1.317 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.351352e-02 | 1.361 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.808471e-02 | 1.318 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.582013e-02 | 1.339 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.625633e-02 | 1.335 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.869631e-02 | 1.313 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.869631e-02 | 1.313 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.869631e-02 | 1.313 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.890652e-02 | 1.311 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.890652e-02 | 1.311 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.890652e-02 | 1.311 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.046159e-02 | 1.297 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.046159e-02 | 1.297 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.046159e-02 | 1.297 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.099819e-02 | 1.292 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.152384e-02 | 1.288 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.152384e-02 | 1.288 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.152384e-02 | 1.288 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.921008e-02 | 1.228 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.921008e-02 | 1.228 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.241272e-02 | 1.281 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.986925e-02 | 1.223 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.277275e-02 | 1.278 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.986925e-02 | 1.223 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.534715e-02 | 1.257 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.579243e-02 | 1.253 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.241272e-02 | 1.281 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.534715e-02 | 1.257 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.921008e-02 | 1.228 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.986925e-02 | 1.223 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.044940e-02 | 1.219 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.129713e-02 | 1.213 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.342822e-02 | 1.198 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.449938e-02 | 1.190 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.505704e-02 | 1.187 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.505704e-02 | 1.187 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.624172e-02 | 1.179 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.624172e-02 | 1.179 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.624172e-02 | 1.179 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.624172e-02 | 1.179 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.838973e-02 | 1.106 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.838973e-02 | 1.106 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.838973e-02 | 1.106 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.838973e-02 | 1.106 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.838973e-02 | 1.106 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.025338e-02 | 1.096 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.695548e-02 | 1.114 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.925789e-02 | 1.160 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.838973e-02 | 1.106 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.040600e-02 | 1.152 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.185704e-02 | 1.144 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.189156e-02 | 1.143 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.005707e-02 | 1.097 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.764419e-02 | 1.110 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.116997e-02 | 1.148 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.025338e-02 | 1.096 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.379496e-02 | 1.077 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.379496e-02 | 1.077 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.379496e-02 | 1.077 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.379496e-02 | 1.077 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.379496e-02 | 1.077 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.533564e-02 | 1.069 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.533564e-02 | 1.069 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.663175e-02 | 1.062 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.692215e-02 | 1.061 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.863317e-02 | 1.052 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.916400e-02 | 1.050 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.916400e-02 | 1.050 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.941305e-02 | 1.049 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 9.703817e-02 | 1.013 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 9.703817e-02 | 1.013 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 9.703817e-02 | 1.013 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.781895e-02 | 1.010 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.077535e-01 | 0.968 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.043518e-02 | 1.044 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.043518e-02 | 1.044 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.043518e-02 | 1.044 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.015318e-01 | 0.993 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.015318e-01 | 0.993 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.015318e-01 | 0.993 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.015318e-01 | 0.993 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.907637e-02 | 1.004 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.924570e-02 | 1.003 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.019844e-01 | 0.991 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.850539e-02 | 1.007 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.043518e-02 | 1.044 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.907637e-02 | 1.004 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.703817e-02 | 1.013 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.490946e-02 | 1.023 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.740616e-02 | 1.011 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.924570e-02 | 1.003 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.924570e-02 | 1.003 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.924570e-02 | 1.003 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.924570e-02 | 1.003 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.504097e-02 | 1.022 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.038639e-01 | 0.984 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.054782e-02 | 1.043 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.043518e-02 | 1.044 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.924570e-02 | 1.003 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.077535e-01 | 0.968 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.674323e-02 | 1.014 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.907637e-02 | 1.004 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.087010e-01 | 0.964 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.087010e-01 | 0.964 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.087010e-01 | 0.964 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.087010e-01 | 0.964 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.087010e-01 | 0.964 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.099498e-01 | 0.959 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.099498e-01 | 0.959 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.099498e-01 | 0.959 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.101615e-01 | 0.958 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.129439e-01 | 0.947 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.133334e-01 | 0.946 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.133334e-01 | 0.946 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.143373e-01 | 0.942 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.153143e-01 | 0.938 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.153143e-01 | 0.938 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.162469e-01 | 0.935 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.169766e-01 | 0.932 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.205657e-01 | 0.919 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.215170e-01 | 0.915 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.216226e-01 | 0.915 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.524654e-01 | 0.817 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.524654e-01 | 0.817 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.524654e-01 | 0.817 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.524654e-01 | 0.817 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.524654e-01 | 0.817 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.524654e-01 | 0.817 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.524654e-01 | 0.817 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.524654e-01 | 0.817 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.524654e-01 | 0.817 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.524654e-01 | 0.817 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.524654e-01 | 0.817 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.524654e-01 | 0.817 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.350263e-01 | 0.870 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.350263e-01 | 0.870 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.291157e-01 | 0.889 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.462704e-01 | 0.835 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.527612e-01 | 0.816 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.319744e-01 | 0.880 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.319744e-01 | 0.880 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.415197e-01 | 0.849 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.401457e-01 | 0.853 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.531666e-01 | 0.815 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.360046e-01 | 0.866 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.527612e-01 | 0.816 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.512100e-01 | 0.820 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.303867e-01 | 0.885 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.381685e-01 | 0.860 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.391651e-01 | 0.856 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.259743e-01 | 0.900 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.289016e-01 | 0.890 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.289016e-01 | 0.890 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.346906e-01 | 0.871 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.392197e-01 | 0.856 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.291157e-01 | 0.889 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.455831e-01 | 0.837 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.485434e-01 | 0.828 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.524654e-01 | 0.817 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.349669e-01 | 0.870 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.391678e-01 | 0.856 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.268713e-01 | 0.897 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.319744e-01 | 0.880 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.512100e-01 | 0.820 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.055917e-01 | 0.687 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.055917e-01 | 0.687 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.055917e-01 | 0.687 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.055917e-01 | 0.687 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.919548e-01 | 0.535 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.919548e-01 | 0.535 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.919548e-01 | 0.535 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.919548e-01 | 0.535 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.919548e-01 | 0.535 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.919548e-01 | 0.535 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.919548e-01 | 0.535 | 0 | 0 |
| Defective APRT disrupts adenine salvage | R-HSA-9734195 | 2.919548e-01 | 0.535 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.919548e-01 | 0.535 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.919548e-01 | 0.535 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.931718e-01 | 0.714 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.931718e-01 | 0.714 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.618408e-01 | 0.791 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.618408e-01 | 0.791 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.618408e-01 | 0.791 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.350466e-01 | 0.629 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.350466e-01 | 0.629 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.350466e-01 | 0.629 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.689335e-01 | 0.433 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.689335e-01 | 0.433 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.689335e-01 | 0.433 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.689335e-01 | 0.433 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.689335e-01 | 0.433 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.689335e-01 | 0.433 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.689335e-01 | 0.433 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.900818e-01 | 0.721 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.900818e-01 | 0.721 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.900818e-01 | 0.721 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.900818e-01 | 0.721 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.558676e-01 | 0.807 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.773553e-01 | 0.557 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.773553e-01 | 0.557 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.194453e-01 | 0.659 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.194453e-01 | 0.659 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.194453e-01 | 0.659 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.194453e-01 | 0.659 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.194453e-01 | 0.659 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.194453e-01 | 0.659 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.194453e-01 | 0.659 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.778786e-01 | 0.750 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.778786e-01 | 0.750 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.643362e-01 | 0.784 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.008563e-01 | 0.697 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.496417e-01 | 0.603 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.496417e-01 | 0.603 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.195091e-01 | 0.496 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.195091e-01 | 0.496 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.195091e-01 | 0.496 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.375472e-01 | 0.359 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.375472e-01 | 0.359 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.375472e-01 | 0.359 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.375472e-01 | 0.359 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.375472e-01 | 0.359 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.375472e-01 | 0.359 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.375472e-01 | 0.359 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.375472e-01 | 0.359 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.375472e-01 | 0.359 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.375472e-01 | 0.359 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.375472e-01 | 0.359 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.246542e-01 | 0.648 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.246542e-01 | 0.648 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.246542e-01 | 0.648 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.246542e-01 | 0.648 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.672039e-01 | 0.777 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.803997e-01 | 0.552 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.803997e-01 | 0.552 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.803997e-01 | 0.552 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.803997e-01 | 0.552 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.803997e-01 | 0.552 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.803997e-01 | 0.552 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.803997e-01 | 0.552 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.803997e-01 | 0.552 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.803997e-01 | 0.552 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.028839e-01 | 0.693 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.610421e-01 | 0.442 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.610421e-01 | 0.442 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.610421e-01 | 0.442 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.610421e-01 | 0.442 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.231964e-01 | 0.651 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.114691e-01 | 0.507 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.190173e-01 | 0.660 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.190173e-01 | 0.660 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.190173e-01 | 0.660 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.373773e-01 | 0.625 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.373773e-01 | 0.625 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.373773e-01 | 0.625 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.654568e-01 | 0.576 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.654568e-01 | 0.576 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.995192e-01 | 0.524 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.995192e-01 | 0.524 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.426227e-01 | 0.465 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.015911e-01 | 0.396 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 4.987042e-01 | 0.302 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.987042e-01 | 0.302 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.987042e-01 | 0.302 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.987042e-01 | 0.302 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.987042e-01 | 0.302 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.830162e-01 | 0.738 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.251669e-01 | 0.488 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.251669e-01 | 0.488 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.251669e-01 | 0.488 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.251669e-01 | 0.488 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.251669e-01 | 0.488 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.469185e-01 | 0.607 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.753705e-01 | 0.560 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.736568e-01 | 0.428 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.831908e-01 | 0.737 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.509440e-01 | 0.455 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.408794e-01 | 0.356 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.981826e-01 | 0.703 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.253296e-01 | 0.647 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.043912e-01 | 0.393 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.994965e-01 | 0.524 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.994965e-01 | 0.524 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.994965e-01 | 0.524 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.857649e-01 | 0.544 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.857649e-01 | 0.544 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.857649e-01 | 0.544 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.767315e-01 | 0.424 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.037734e-01 | 0.517 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.357632e-01 | 0.474 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.357632e-01 | 0.474 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.357632e-01 | 0.474 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.357632e-01 | 0.474 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.357632e-01 | 0.474 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.024191e-01 | 0.395 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.787019e-01 | 0.320 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.787019e-01 | 0.320 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.532147e-01 | 0.257 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.532147e-01 | 0.257 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.532147e-01 | 0.257 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.532147e-01 | 0.257 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.193567e-01 | 0.496 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.990267e-01 | 0.399 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.990267e-01 | 0.399 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.725773e-01 | 0.429 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.035210e-01 | 0.518 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.643538e-01 | 0.333 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.973764e-01 | 0.527 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.149130e-01 | 0.288 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.149130e-01 | 0.288 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.149130e-01 | 0.288 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.248260e-01 | 0.488 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.095888e-01 | 0.388 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.933323e-01 | 0.307 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.933323e-01 | 0.307 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.779179e-01 | 0.321 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.807828e-01 | 0.419 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.093682e-01 | 0.388 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.555511e-01 | 0.341 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.494159e-01 | 0.260 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.494159e-01 | 0.260 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.018007e-01 | 0.221 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.018007e-01 | 0.221 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.018007e-01 | 0.221 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.018007e-01 | 0.221 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.018007e-01 | 0.221 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.018007e-01 | 0.221 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.018007e-01 | 0.221 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.018007e-01 | 0.221 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.018007e-01 | 0.221 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.018007e-01 | 0.221 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.088732e-01 | 0.293 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.893698e-01 | 0.310 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.261437e-01 | 0.279 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.849734e-01 | 0.314 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.812350e-01 | 0.318 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.141704e-01 | 0.289 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.488068e-01 | 0.261 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.494313e-01 | 0.260 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.494313e-01 | 0.260 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.821540e-01 | 0.235 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.821540e-01 | 0.235 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.821540e-01 | 0.235 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.154606e-01 | 0.288 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.505751e-01 | 0.259 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.505751e-01 | 0.259 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.534594e-01 | 0.257 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.721028e-01 | 0.243 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.721028e-01 | 0.243 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.721028e-01 | 0.243 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.721028e-01 | 0.243 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.612506e-01 | 0.251 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.005371e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.005371e-01 | 0.221 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.005371e-01 | 0.221 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.131031e-01 | 0.212 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.022874e-01 | 0.299 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.505751e-01 | 0.259 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.729966e-01 | 0.325 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.509440e-01 | 0.455 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.509440e-01 | 0.455 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.491260e-01 | 0.604 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.491260e-01 | 0.604 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.872262e-01 | 0.542 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.079489e-01 | 0.682 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.278078e-01 | 0.369 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.933323e-01 | 0.307 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.941188e-01 | 0.226 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.671551e-01 | 0.777 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.765433e-01 | 0.424 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.990267e-01 | 0.399 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.299307e-01 | 0.276 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.598653e-01 | 0.337 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.246542e-01 | 0.648 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.751649e-01 | 0.240 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.721028e-01 | 0.243 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.741275e-01 | 0.562 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.169430e-01 | 0.664 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.346192e-01 | 0.475 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.299307e-01 | 0.276 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.654568e-01 | 0.576 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.654568e-01 | 0.576 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.803997e-01 | 0.552 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.261437e-01 | 0.279 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.565814e-01 | 0.254 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.695232e-01 | 0.569 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.015006e-01 | 0.696 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.933323e-01 | 0.307 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.864731e-01 | 0.232 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.496417e-01 | 0.603 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.671551e-01 | 0.777 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.015911e-01 | 0.396 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.408794e-01 | 0.356 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.779179e-01 | 0.321 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.191230e-01 | 0.496 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.215090e-01 | 0.283 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.110061e-01 | 0.214 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.350466e-01 | 0.629 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.195091e-01 | 0.496 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.610421e-01 | 0.442 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.408794e-01 | 0.356 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.408794e-01 | 0.356 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.787019e-01 | 0.320 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.666068e-01 | 0.574 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.018007e-01 | 0.221 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.597096e-01 | 0.252 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.131031e-01 | 0.212 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.316042e-01 | 0.479 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.373773e-01 | 0.625 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.088732e-01 | 0.293 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.857649e-01 | 0.544 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.346192e-01 | 0.475 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.643362e-01 | 0.784 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.261437e-01 | 0.279 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.919548e-01 | 0.535 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.618408e-01 | 0.791 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.618408e-01 | 0.791 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.803997e-01 | 0.552 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.803997e-01 | 0.552 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.803997e-01 | 0.552 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.231964e-01 | 0.651 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 4.346686e-01 | 0.362 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.908269e-01 | 0.536 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.279058e-01 | 0.369 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.554172e-01 | 0.342 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.215090e-01 | 0.283 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.018007e-01 | 0.221 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.526724e-01 | 0.344 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.261437e-01 | 0.279 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.904822e-01 | 0.229 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.881596e-01 | 0.540 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.118076e-01 | 0.506 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.339345e-01 | 0.476 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.995192e-01 | 0.524 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.346686e-01 | 0.362 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.862564e-01 | 0.232 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.151489e-01 | 0.382 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.496417e-01 | 0.603 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.022467e-01 | 0.520 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.933323e-01 | 0.307 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.245649e-01 | 0.372 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.305736e-01 | 0.275 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.910795e-01 | 0.408 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.910795e-01 | 0.408 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.669334e-01 | 0.435 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.874445e-01 | 0.312 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.850147e-01 | 0.733 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.043034e-01 | 0.297 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.088732e-01 | 0.293 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.977206e-01 | 0.704 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.328020e-01 | 0.364 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.931718e-01 | 0.714 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.900818e-01 | 0.721 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.778786e-01 | 0.750 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.008563e-01 | 0.697 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.496417e-01 | 0.603 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.440838e-01 | 0.612 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.426227e-01 | 0.465 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.015911e-01 | 0.396 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.015911e-01 | 0.396 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.787019e-01 | 0.320 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.532147e-01 | 0.257 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.532147e-01 | 0.257 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.656911e-01 | 0.332 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.092102e-01 | 0.388 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.018007e-01 | 0.221 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.305736e-01 | 0.275 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.581512e-01 | 0.253 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.725773e-01 | 0.429 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.948261e-01 | 0.306 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.110061e-01 | 0.214 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.190952e-01 | 0.496 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.953083e-01 | 0.709 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.022874e-01 | 0.299 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.146502e-01 | 0.502 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.951347e-01 | 0.403 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.293176e-01 | 0.276 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.945688e-01 | 0.531 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.535573e-01 | 0.596 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.095888e-01 | 0.388 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.496417e-01 | 0.603 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.803997e-01 | 0.552 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.114691e-01 | 0.507 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.295323e-01 | 0.367 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.412653e-01 | 0.467 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.408794e-01 | 0.356 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.290619e-01 | 0.640 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.350466e-01 | 0.629 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.375472e-01 | 0.359 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.610421e-01 | 0.442 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.987042e-01 | 0.302 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.643538e-01 | 0.333 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.752287e-01 | 0.323 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.821540e-01 | 0.235 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.429145e-01 | 0.354 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.043281e-01 | 0.297 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.858220e-01 | 0.544 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.022874e-01 | 0.299 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.684615e-01 | 0.571 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.773553e-01 | 0.557 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 4.987042e-01 | 0.302 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.509440e-01 | 0.455 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.707573e-01 | 0.768 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.752287e-01 | 0.323 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.597096e-01 | 0.252 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.968840e-01 | 0.224 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.561822e-01 | 0.591 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.034670e-01 | 0.219 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.895573e-01 | 0.722 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.671551e-01 | 0.777 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.426725e-01 | 0.465 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.389378e-01 | 0.358 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.791619e-01 | 0.320 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.044595e-01 | 0.516 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.530995e-01 | 0.344 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.516105e-01 | 0.454 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.548052e-01 | 0.342 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.183700e-01 | 0.378 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.263466e-01 | 0.370 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.175390e-01 | 0.498 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.189114e-01 | 0.285 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.862245e-01 | 0.232 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.313720e-01 | 0.636 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.948261e-01 | 0.306 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.450014e-01 | 0.352 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.113661e-01 | 0.386 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.055917e-01 | 0.687 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.919548e-01 | 0.535 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.919548e-01 | 0.535 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.931718e-01 | 0.714 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.618408e-01 | 0.791 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.689335e-01 | 0.433 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.778786e-01 | 0.750 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.008563e-01 | 0.697 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.496417e-01 | 0.603 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.195091e-01 | 0.496 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.375472e-01 | 0.359 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.610421e-01 | 0.442 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.610421e-01 | 0.442 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.426227e-01 | 0.465 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.015911e-01 | 0.396 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.987042e-01 | 0.302 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.987042e-01 | 0.302 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.777657e-01 | 0.750 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.346192e-01 | 0.475 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.244453e-01 | 0.649 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.532147e-01 | 0.257 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.829718e-01 | 0.417 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.874445e-01 | 0.312 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.874445e-01 | 0.312 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.022874e-01 | 0.299 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.022874e-01 | 0.299 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.018007e-01 | 0.221 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.018007e-01 | 0.221 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.018007e-01 | 0.221 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.005371e-01 | 0.221 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.000019e-01 | 0.222 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.272976e-01 | 0.369 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.539301e-01 | 0.451 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.941460e-01 | 0.226 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.555511e-01 | 0.341 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.088732e-01 | 0.293 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.465890e-01 | 0.460 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.708718e-01 | 0.243 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.708718e-01 | 0.243 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.408794e-01 | 0.356 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.899104e-01 | 0.721 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.714368e-01 | 0.566 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.779179e-01 | 0.321 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.215090e-01 | 0.283 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.509657e-01 | 0.455 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.990267e-01 | 0.399 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.299307e-01 | 0.276 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.469185e-01 | 0.607 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.994965e-01 | 0.524 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.195091e-01 | 0.496 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.195091e-01 | 0.496 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.532147e-01 | 0.257 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.153235e-01 | 0.382 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.426725e-01 | 0.465 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.018007e-01 | 0.221 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.018007e-01 | 0.221 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.272976e-01 | 0.369 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.043034e-01 | 0.297 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.895227e-01 | 0.409 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.535573e-01 | 0.596 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.765433e-01 | 0.424 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.821540e-01 | 0.235 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.175390e-01 | 0.498 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.246542e-01 | 0.648 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.857649e-01 | 0.544 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.494159e-01 | 0.260 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.280647e-01 | 0.368 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.919548e-01 | 0.535 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.931718e-01 | 0.714 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.773553e-01 | 0.557 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.375472e-01 | 0.359 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.976201e-01 | 0.704 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.987042e-01 | 0.302 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.987042e-01 | 0.302 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.753705e-01 | 0.560 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.509440e-01 | 0.455 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.408794e-01 | 0.356 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.857649e-01 | 0.544 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.615970e-01 | 0.582 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.530995e-01 | 0.344 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.149130e-01 | 0.288 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.149130e-01 | 0.288 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.436649e-01 | 0.353 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.213491e-01 | 0.375 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.220712e-01 | 0.375 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.141704e-01 | 0.289 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.751649e-01 | 0.240 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.721028e-01 | 0.243 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.005371e-01 | 0.221 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.131031e-01 | 0.212 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.215090e-01 | 0.283 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.175390e-01 | 0.498 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.695232e-01 | 0.569 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.299307e-01 | 0.276 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.028839e-01 | 0.693 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.375472e-01 | 0.359 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.547279e-01 | 0.450 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.787019e-01 | 0.320 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.131031e-01 | 0.212 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.261437e-01 | 0.279 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.998780e-01 | 0.301 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.751649e-01 | 0.240 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.849734e-01 | 0.314 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 2.350466e-01 | 0.629 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.643538e-01 | 0.333 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.839488e-01 | 0.315 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.751649e-01 | 0.240 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.689335e-01 | 0.433 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.195091e-01 | 0.496 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.375472e-01 | 0.359 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.375472e-01 | 0.359 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.043912e-01 | 0.393 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.568016e-01 | 0.590 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.656911e-01 | 0.332 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.022874e-01 | 0.299 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.018007e-01 | 0.221 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.018007e-01 | 0.221 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.494313e-01 | 0.260 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.821540e-01 | 0.235 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.690279e-01 | 0.772 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.477703e-01 | 0.459 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.751649e-01 | 0.240 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.926044e-01 | 0.534 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.174535e-01 | 0.663 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.248260e-01 | 0.488 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.024191e-01 | 0.395 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.674655e-01 | 0.573 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.931718e-01 | 0.714 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.976201e-01 | 0.704 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.153235e-01 | 0.382 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.018007e-01 | 0.221 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.582569e-01 | 0.588 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.905166e-01 | 0.309 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.749184e-01 | 0.426 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.043912e-01 | 0.393 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.028839e-01 | 0.693 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 3.426227e-01 | 0.465 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.933323e-01 | 0.307 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.088732e-01 | 0.293 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.131031e-01 | 0.212 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.492819e-01 | 0.603 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.899680e-01 | 0.538 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.018007e-01 | 0.221 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.494159e-01 | 0.260 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.532147e-01 | 0.257 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.408794e-01 | 0.356 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.821540e-01 | 0.235 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.494159e-01 | 0.260 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.131031e-01 | 0.212 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.933323e-01 | 0.307 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.154471e-01 | 0.211 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.154471e-01 | 0.211 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.224539e-01 | 0.206 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.231362e-01 | 0.205 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.248906e-01 | 0.204 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.248906e-01 | 0.204 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.248906e-01 | 0.204 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.248906e-01 | 0.204 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.252462e-01 | 0.204 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.271089e-01 | 0.203 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.283560e-01 | 0.202 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.283560e-01 | 0.202 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.288727e-01 | 0.201 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.315604e-01 | 0.200 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.347117e-01 | 0.197 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.360559e-01 | 0.197 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.360627e-01 | 0.197 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.360627e-01 | 0.197 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.377459e-01 | 0.195 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.398710e-01 | 0.194 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.399949e-01 | 0.194 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.412861e-01 | 0.193 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.422652e-01 | 0.192 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.422652e-01 | 0.192 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.422652e-01 | 0.192 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.422652e-01 | 0.192 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.422652e-01 | 0.192 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.422652e-01 | 0.192 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.422652e-01 | 0.192 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.422652e-01 | 0.192 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.422652e-01 | 0.192 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.422652e-01 | 0.192 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.422652e-01 | 0.192 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.422652e-01 | 0.192 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.422652e-01 | 0.192 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.422652e-01 | 0.192 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.451056e-01 | 0.190 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.451056e-01 | 0.190 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.451056e-01 | 0.190 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.451056e-01 | 0.190 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.451056e-01 | 0.190 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.451056e-01 | 0.190 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.451056e-01 | 0.190 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.451056e-01 | 0.190 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.464752e-01 | 0.189 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.464752e-01 | 0.189 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.482043e-01 | 0.188 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.482043e-01 | 0.188 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.482043e-01 | 0.188 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.482043e-01 | 0.188 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.482043e-01 | 0.188 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.503810e-01 | 0.187 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.503810e-01 | 0.187 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.559466e-01 | 0.183 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.559466e-01 | 0.183 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.559466e-01 | 0.183 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.561814e-01 | 0.183 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.620676e-01 | 0.179 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.640280e-01 | 0.178 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.696628e-01 | 0.174 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.696628e-01 | 0.174 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.696628e-01 | 0.174 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.696628e-01 | 0.174 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.696628e-01 | 0.174 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.696628e-01 | 0.174 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.696628e-01 | 0.174 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.696628e-01 | 0.174 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.704676e-01 | 0.174 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.704676e-01 | 0.174 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.704676e-01 | 0.174 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.720121e-01 | 0.173 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.738020e-01 | 0.171 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.738020e-01 | 0.171 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.738758e-01 | 0.171 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.750861e-01 | 0.171 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.767158e-01 | 0.170 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.774919e-01 | 0.169 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.797527e-01 | 0.168 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.797527e-01 | 0.168 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.797527e-01 | 0.168 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.818612e-01 | 0.166 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.837033e-01 | 0.165 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.837033e-01 | 0.165 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.837033e-01 | 0.165 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.837033e-01 | 0.165 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.837033e-01 | 0.165 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.837033e-01 | 0.165 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.837033e-01 | 0.165 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.837033e-01 | 0.165 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.837033e-01 | 0.165 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.837033e-01 | 0.165 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.837033e-01 | 0.165 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.837033e-01 | 0.165 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.837033e-01 | 0.165 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.837033e-01 | 0.165 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.837033e-01 | 0.165 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.837033e-01 | 0.165 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.837033e-01 | 0.165 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.854408e-01 | 0.164 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.869340e-01 | 0.163 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.869340e-01 | 0.163 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.873694e-01 | 0.163 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.895501e-01 | 0.161 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.897236e-01 | 0.161 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.916788e-01 | 0.160 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.934732e-01 | 0.159 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.934732e-01 | 0.159 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.953348e-01 | 0.158 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.953348e-01 | 0.158 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.953348e-01 | 0.158 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.953348e-01 | 0.158 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.953348e-01 | 0.158 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.953348e-01 | 0.158 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.953348e-01 | 0.158 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.973925e-01 | 0.157 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.012269e-01 | 0.154 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.014029e-01 | 0.154 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.022462e-01 | 0.154 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.022462e-01 | 0.154 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.078221e-01 | 0.150 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.106348e-01 | 0.148 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.118439e-01 | 0.148 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.118439e-01 | 0.148 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.126752e-01 | 0.147 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.131915e-01 | 0.147 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.141613e-01 | 0.146 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.145867e-01 | 0.146 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.181053e-01 | 0.144 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.181053e-01 | 0.144 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.181053e-01 | 0.144 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.181053e-01 | 0.144 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.181053e-01 | 0.144 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.181053e-01 | 0.144 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.181053e-01 | 0.144 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.181053e-01 | 0.144 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.181053e-01 | 0.144 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.181053e-01 | 0.144 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.181053e-01 | 0.144 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.181053e-01 | 0.144 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.181053e-01 | 0.144 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.181053e-01 | 0.144 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.181053e-01 | 0.144 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.181053e-01 | 0.144 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.181053e-01 | 0.144 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.193323e-01 | 0.143 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.193323e-01 | 0.143 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.193323e-01 | 0.143 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.193323e-01 | 0.143 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.193323e-01 | 0.143 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.230982e-01 | 0.141 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.244070e-01 | 0.140 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.252866e-01 | 0.139 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.279839e-01 | 0.138 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.279839e-01 | 0.138 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.279839e-01 | 0.138 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.283984e-01 | 0.138 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.283984e-01 | 0.138 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.283984e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.309759e-01 | 0.136 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.309759e-01 | 0.136 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.347155e-01 | 0.134 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.347155e-01 | 0.134 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.354353e-01 | 0.133 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.354353e-01 | 0.133 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.354353e-01 | 0.133 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.379450e-01 | 0.132 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.394672e-01 | 0.131 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.417159e-01 | 0.130 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.417159e-01 | 0.130 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.417159e-01 | 0.130 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.417159e-01 | 0.130 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.417159e-01 | 0.130 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.425668e-01 | 0.129 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.430141e-01 | 0.129 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.439563e-01 | 0.128 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.439563e-01 | 0.128 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.487672e-01 | 0.126 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.487672e-01 | 0.126 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.487672e-01 | 0.126 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.487672e-01 | 0.126 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.487672e-01 | 0.126 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.487672e-01 | 0.126 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.487672e-01 | 0.126 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.487672e-01 | 0.126 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.487672e-01 | 0.126 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.490931e-01 | 0.125 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.490931e-01 | 0.125 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.568837e-01 | 0.121 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.568837e-01 | 0.121 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.587671e-01 | 0.120 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.592526e-01 | 0.120 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.595044e-01 | 0.119 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.596063e-01 | 0.119 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.621037e-01 | 0.118 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.625527e-01 | 0.118 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.625527e-01 | 0.118 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.625527e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.625527e-01 | 0.118 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.625527e-01 | 0.118 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.625527e-01 | 0.118 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.662187e-01 | 0.116 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.662187e-01 | 0.116 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.662187e-01 | 0.116 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.687486e-01 | 0.114 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.696824e-01 | 0.114 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.696824e-01 | 0.114 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.731116e-01 | 0.112 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.741667e-01 | 0.111 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.741667e-01 | 0.111 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.760957e-01 | 0.110 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.760957e-01 | 0.110 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.760957e-01 | 0.110 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.760957e-01 | 0.110 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.760957e-01 | 0.110 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.760957e-01 | 0.110 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.760957e-01 | 0.110 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.760957e-01 | 0.110 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.760957e-01 | 0.110 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.760957e-01 | 0.110 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.760957e-01 | 0.110 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.760957e-01 | 0.110 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.760957e-01 | 0.110 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 7.815222e-01 | 0.107 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.815222e-01 | 0.107 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.819143e-01 | 0.107 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.819143e-01 | 0.107 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.819143e-01 | 0.107 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.819143e-01 | 0.107 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.819143e-01 | 0.107 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.819143e-01 | 0.107 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.819143e-01 | 0.107 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.819143e-01 | 0.107 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.823797e-01 | 0.107 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.833565e-01 | 0.106 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.833565e-01 | 0.106 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.833565e-01 | 0.106 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.833565e-01 | 0.106 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.833565e-01 | 0.106 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.856876e-01 | 0.105 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.868720e-01 | 0.104 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.881149e-01 | 0.103 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.881149e-01 | 0.103 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.881149e-01 | 0.103 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.881149e-01 | 0.103 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.916502e-01 | 0.101 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.916848e-01 | 0.101 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.932953e-01 | 0.101 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.947155e-01 | 0.100 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.956601e-01 | 0.099 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.956601e-01 | 0.099 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.976060e-01 | 0.098 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.976060e-01 | 0.098 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.976060e-01 | 0.098 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.977016e-01 | 0.098 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.998750e-01 | 0.097 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.998750e-01 | 0.097 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.004529e-01 | 0.097 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.004529e-01 | 0.097 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.004529e-01 | 0.097 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.004529e-01 | 0.097 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 8.004529e-01 | 0.097 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.004529e-01 | 0.097 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.004529e-01 | 0.097 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.004529e-01 | 0.097 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.004529e-01 | 0.097 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.004529e-01 | 0.097 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.004529e-01 | 0.097 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.004529e-01 | 0.097 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.004529e-01 | 0.097 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.013654e-01 | 0.096 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.013654e-01 | 0.096 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.057760e-01 | 0.094 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.074083e-01 | 0.093 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.139363e-01 | 0.089 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.139363e-01 | 0.089 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.143490e-01 | 0.089 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.165104e-01 | 0.088 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.165104e-01 | 0.088 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.195849e-01 | 0.086 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.215824e-01 | 0.085 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.221617e-01 | 0.085 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.221617e-01 | 0.085 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.221617e-01 | 0.085 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.221617e-01 | 0.085 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.221617e-01 | 0.085 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.244539e-01 | 0.084 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.253862e-01 | 0.083 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.253862e-01 | 0.083 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.253862e-01 | 0.083 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.253862e-01 | 0.083 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.258470e-01 | 0.083 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.258470e-01 | 0.083 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.258470e-01 | 0.083 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.258470e-01 | 0.083 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.292867e-01 | 0.081 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.307784e-01 | 0.081 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.318962e-01 | 0.080 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.318962e-01 | 0.080 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.318962e-01 | 0.080 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.318962e-01 | 0.080 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.341164e-01 | 0.079 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.371184e-01 | 0.077 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.373761e-01 | 0.077 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.380097e-01 | 0.077 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.380097e-01 | 0.077 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.394439e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.415099e-01 | 0.075 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.415099e-01 | 0.075 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.415099e-01 | 0.075 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.415099e-01 | 0.075 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.415099e-01 | 0.075 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.415099e-01 | 0.075 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.415099e-01 | 0.075 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.461074e-01 | 0.073 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.461074e-01 | 0.073 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.461074e-01 | 0.073 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.461074e-01 | 0.073 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.461074e-01 | 0.073 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.477722e-01 | 0.072 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.498369e-01 | 0.071 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.498369e-01 | 0.071 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.499786e-01 | 0.071 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.510558e-01 | 0.070 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.512747e-01 | 0.070 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.578307e-01 | 0.067 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.587541e-01 | 0.066 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.587541e-01 | 0.066 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.587541e-01 | 0.066 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.587541e-01 | 0.066 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.587541e-01 | 0.066 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.587541e-01 | 0.066 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.587541e-01 | 0.066 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.587541e-01 | 0.066 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.587541e-01 | 0.066 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.587541e-01 | 0.066 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.592173e-01 | 0.066 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.592173e-01 | 0.066 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.592173e-01 | 0.066 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.592173e-01 | 0.066 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.635893e-01 | 0.064 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.673168e-01 | 0.062 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.673168e-01 | 0.062 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.685552e-01 | 0.061 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.707402e-01 | 0.060 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.712489e-01 | 0.060 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.712489e-01 | 0.060 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.712974e-01 | 0.060 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.712974e-01 | 0.060 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.712974e-01 | 0.060 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.712974e-01 | 0.060 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.712974e-01 | 0.060 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.712974e-01 | 0.060 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.718924e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.741229e-01 | 0.058 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.741229e-01 | 0.058 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.741229e-01 | 0.058 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.741229e-01 | 0.058 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.741229e-01 | 0.058 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.741229e-01 | 0.058 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.741229e-01 | 0.058 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.741229e-01 | 0.058 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.741229e-01 | 0.058 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.741229e-01 | 0.058 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.741229e-01 | 0.058 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.747614e-01 | 0.058 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.752089e-01 | 0.058 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.761950e-01 | 0.057 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.762536e-01 | 0.057 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.762536e-01 | 0.057 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.783007e-01 | 0.056 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.784043e-01 | 0.056 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.794387e-01 | 0.056 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.809070e-01 | 0.055 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.809070e-01 | 0.055 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.809070e-01 | 0.055 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.809070e-01 | 0.055 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.811278e-01 | 0.055 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.824164e-01 | 0.054 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.824164e-01 | 0.054 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.824164e-01 | 0.054 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.830140e-01 | 0.054 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.835396e-01 | 0.054 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.846644e-01 | 0.053 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.846644e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.878203e-01 | 0.052 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.878203e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.878203e-01 | 0.052 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.878203e-01 | 0.052 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.878203e-01 | 0.052 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.878203e-01 | 0.052 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.878203e-01 | 0.052 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.878203e-01 | 0.052 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.878203e-01 | 0.052 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.878203e-01 | 0.052 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.899142e-01 | 0.051 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.899142e-01 | 0.051 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.899144e-01 | 0.051 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.902912e-01 | 0.050 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.902912e-01 | 0.050 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.902912e-01 | 0.050 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.926405e-01 | 0.049 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.926405e-01 | 0.049 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.926405e-01 | 0.049 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.926405e-01 | 0.049 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.926405e-01 | 0.049 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.930260e-01 | 0.049 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.933155e-01 | 0.049 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.933155e-01 | 0.049 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.946058e-01 | 0.048 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.968229e-01 | 0.047 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.973759e-01 | 0.047 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.983066e-01 | 0.047 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.000280e-01 | 0.046 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.000280e-01 | 0.046 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.000280e-01 | 0.046 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.000280e-01 | 0.046 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 9.000280e-01 | 0.046 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.000280e-01 | 0.046 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.015975e-01 | 0.045 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.020326e-01 | 0.045 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.030189e-01 | 0.044 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.039659e-01 | 0.044 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.039659e-01 | 0.044 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.061179e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.065502e-01 | 0.043 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.084306e-01 | 0.042 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.097755e-01 | 0.041 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.101838e-01 | 0.041 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.106528e-01 | 0.041 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.106744e-01 | 0.041 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.109078e-01 | 0.041 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.109078e-01 | 0.041 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.109078e-01 | 0.041 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.109078e-01 | 0.041 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.109078e-01 | 0.041 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.109078e-01 | 0.041 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.109078e-01 | 0.041 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.109078e-01 | 0.041 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.135081e-01 | 0.039 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.135081e-01 | 0.039 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.135081e-01 | 0.039 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.140052e-01 | 0.039 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.147392e-01 | 0.039 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.167216e-01 | 0.038 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.167216e-01 | 0.038 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.185577e-01 | 0.037 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.196317e-01 | 0.036 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.196317e-01 | 0.036 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.196317e-01 | 0.036 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.201305e-01 | 0.036 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.201305e-01 | 0.036 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.201305e-01 | 0.036 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.206041e-01 | 0.036 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.206041e-01 | 0.036 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.206041e-01 | 0.036 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.206041e-01 | 0.036 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.206041e-01 | 0.036 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.206041e-01 | 0.036 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.206041e-01 | 0.036 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.206041e-01 | 0.036 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.206041e-01 | 0.036 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.206041e-01 | 0.036 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.215682e-01 | 0.035 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.219636e-01 | 0.035 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.221502e-01 | 0.035 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.253637e-01 | 0.034 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.258010e-01 | 0.033 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.258010e-01 | 0.033 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.267663e-01 | 0.033 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.292457e-01 | 0.032 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.292457e-01 | 0.032 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.292457e-01 | 0.032 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.292457e-01 | 0.032 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.292457e-01 | 0.032 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.292457e-01 | 0.032 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.307249e-01 | 0.031 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.307249e-01 | 0.031 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.322061e-01 | 0.030 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.322061e-01 | 0.030 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.323195e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.323195e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.323195e-01 | 0.030 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.323609e-01 | 0.030 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.357354e-01 | 0.029 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.369471e-01 | 0.028 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.369471e-01 | 0.028 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.369471e-01 | 0.028 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.369471e-01 | 0.028 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.369471e-01 | 0.028 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.369471e-01 | 0.028 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.369471e-01 | 0.028 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.369471e-01 | 0.028 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.369471e-01 | 0.028 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.375914e-01 | 0.028 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.375914e-01 | 0.028 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.385007e-01 | 0.028 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.387685e-01 | 0.027 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.408465e-01 | 0.026 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.418237e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.438107e-01 | 0.025 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.438107e-01 | 0.025 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.438107e-01 | 0.025 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.438107e-01 | 0.025 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.440487e-01 | 0.025 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.440487e-01 | 0.025 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.440487e-01 | 0.025 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.446195e-01 | 0.025 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.488536e-01 | 0.023 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.491179e-01 | 0.023 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.491179e-01 | 0.023 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.491179e-01 | 0.023 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.493477e-01 | 0.023 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.499275e-01 | 0.022 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.499275e-01 | 0.022 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.499275e-01 | 0.022 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.499275e-01 | 0.022 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.499275e-01 | 0.022 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.499275e-01 | 0.022 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.499275e-01 | 0.022 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.506529e-01 | 0.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.514620e-01 | 0.022 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.514620e-01 | 0.022 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.519818e-01 | 0.021 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.527466e-01 | 0.021 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.527541e-01 | 0.021 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.527987e-01 | 0.021 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.537470e-01 | 0.021 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.537470e-01 | 0.021 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.542996e-01 | 0.020 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.553787e-01 | 0.020 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.553787e-01 | 0.020 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.553787e-01 | 0.020 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.553787e-01 | 0.020 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.553787e-01 | 0.020 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.554062e-01 | 0.020 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.561827e-01 | 0.019 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.561827e-01 | 0.019 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.575319e-01 | 0.019 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.579715e-01 | 0.019 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.579715e-01 | 0.019 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.579715e-01 | 0.019 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.585812e-01 | 0.018 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.586430e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.602368e-01 | 0.018 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.602368e-01 | 0.018 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.602368e-01 | 0.018 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.602368e-01 | 0.018 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.602368e-01 | 0.018 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 9.602368e-01 | 0.018 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.602368e-01 | 0.018 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.602368e-01 | 0.018 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.602368e-01 | 0.018 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.613298e-01 | 0.017 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.613654e-01 | 0.017 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.613654e-01 | 0.017 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.618248e-01 | 0.017 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.618248e-01 | 0.017 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.620045e-01 | 0.017 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.620045e-01 | 0.017 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.625748e-01 | 0.017 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.640983e-01 | 0.016 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.645662e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.645662e-01 | 0.016 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.653376e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.653376e-01 | 0.015 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.653727e-01 | 0.015 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.661417e-01 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.666522e-01 | 0.015 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.671193e-01 | 0.015 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.674968e-01 | 0.014 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.683696e-01 | 0.014 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.683696e-01 | 0.014 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.684244e-01 | 0.014 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.684244e-01 | 0.014 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.684244e-01 | 0.014 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.684244e-01 | 0.014 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.684244e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.685382e-01 | 0.014 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.692681e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.710030e-01 | 0.013 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.714531e-01 | 0.013 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.714531e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.718628e-01 | 0.012 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.718628e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.718628e-01 | 0.012 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.718628e-01 | 0.012 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.718628e-01 | 0.012 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.727451e-01 | 0.012 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.746079e-01 | 0.011 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.748558e-01 | 0.011 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.749269e-01 | 0.011 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.753810e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.756593e-01 | 0.011 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.763596e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.765206e-01 | 0.010 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.776575e-01 | 0.010 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.776575e-01 | 0.010 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.776575e-01 | 0.010 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.776575e-01 | 0.010 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.776575e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.776575e-01 | 0.010 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.777119e-01 | 0.010 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.786248e-01 | 0.009 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.787163e-01 | 0.009 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.787163e-01 | 0.009 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.795989e-01 | 0.009 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.800908e-01 | 0.009 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.800908e-01 | 0.009 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.800908e-01 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.800908e-01 | 0.009 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.800908e-01 | 0.009 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.801717e-01 | 0.009 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.821883e-01 | 0.008 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.822593e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.822593e-01 | 0.008 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.826535e-01 | 0.008 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.841740e-01 | 0.007 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.841740e-01 | 0.007 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.841917e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.841917e-01 | 0.007 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.841917e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.842919e-01 | 0.007 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.843876e-01 | 0.007 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.843876e-01 | 0.007 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.851710e-01 | 0.006 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.852123e-01 | 0.006 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.852123e-01 | 0.006 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.855732e-01 | 0.006 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.855732e-01 | 0.006 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.857293e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.859137e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.859137e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.874482e-01 | 0.005 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.874482e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.879463e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.879463e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.882608e-01 | 0.005 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.882608e-01 | 0.005 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.889658e-01 | 0.005 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.891223e-01 | 0.005 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.893787e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.900342e-01 | 0.004 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.900696e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.910303e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.910303e-01 | 0.004 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.911200e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.911200e-01 | 0.004 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.911200e-01 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.911200e-01 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.911200e-01 | 0.004 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.913115e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.913115e-01 | 0.004 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.913463e-01 | 0.004 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.913463e-01 | 0.004 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.916262e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.917312e-01 | 0.004 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.920574e-01 | 0.003 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.920718e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.920876e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.920876e-01 | 0.003 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.928852e-01 | 0.003 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.929498e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.929498e-01 | 0.003 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.937181e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.937181e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.937181e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.937181e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.937181e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.937304e-01 | 0.003 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.937704e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.942861e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.942861e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.942861e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.944027e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.944027e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.944027e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.950128e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.951816e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.952687e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.955564e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.955564e-01 | 0.002 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.955564e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.955564e-01 | 0.002 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.960407e-01 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.960407e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.960407e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.960407e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.960679e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.961425e-01 | 0.002 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.964723e-01 | 0.002 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.964723e-01 | 0.002 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.964723e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.964723e-01 | 0.002 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.964723e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.965179e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.965179e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.968521e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.968569e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.970366e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.970366e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.970366e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.971150e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.971641e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.971995e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.971995e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.974876e-01 | 0.001 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.975049e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.975049e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.975049e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.975049e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.975049e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.977712e-01 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.977769e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.977769e-01 | 0.001 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.977769e-01 | 0.001 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.977769e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.980193e-01 | 0.001 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.980193e-01 | 0.001 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.980193e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.980790e-01 | 0.001 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.982353e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.982353e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.982937e-01 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.982944e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.983073e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.983073e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.984740e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.985992e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.985992e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.987520e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.987730e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.987773e-01 | 0.001 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.988829e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.988829e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.988881e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.988881e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.988881e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.989935e-01 | 0.000 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.990094e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.990338e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.990680e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.991043e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.991175e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.992644e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.993561e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.993759e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.994285e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994343e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.994629e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.994629e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.995165e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.996069e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.996311e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996498e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.996498e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.996829e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.996949e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997923e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998250e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998279e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998321e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.998403e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.998571e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998619e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.998642e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998898e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999018e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999125e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999125e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999203e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999221e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999272e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999284e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999422e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999510e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999534e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.999534e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999569e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999649e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999653e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.999662e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999755e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999766e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.999844e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.999844e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.999844e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999846e-01 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.999859e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999873e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999885e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999891e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999897e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.999903e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999914e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999931e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999932e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999933e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999955e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999957e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999966e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999967e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999978e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999981e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999985e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999985e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999986e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999987e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999990e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999991e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999995e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.312082e-09 | 8.275 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.437025e-08 | 7.265 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.249053e-06 | 5.903 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.118990e-06 | 5.674 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.202671e-06 | 5.657 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.715595e-06 | 5.566 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.782795e-06 | 5.556 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.339015e-06 | 5.476 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.706288e-06 | 5.431 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.040639e-06 | 5.394 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.313405e-06 | 5.275 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.926324e-06 | 5.307 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.184605e-06 | 5.285 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.896659e-06 | 5.310 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.428071e-06 | 5.074 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.428071e-06 | 5.074 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.030363e-05 | 4.987 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.080570e-05 | 4.966 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.562746e-05 | 4.806 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.979080e-05 | 4.704 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.923146e-05 | 4.534 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.906572e-05 | 4.408 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.959947e-05 | 4.305 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.404008e-05 | 4.267 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.404008e-05 | 4.267 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.911071e-05 | 4.160 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.229187e-05 | 4.085 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.205025e-04 | 3.657 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.184166e-04 | 3.661 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.307920e-04 | 3.637 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.245532e-04 | 3.489 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.873376e-04 | 3.412 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.607084e-04 | 3.337 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.234253e-04 | 3.035 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.105699e-03 | 2.956 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.105699e-03 | 2.956 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.131152e-03 | 2.946 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.473281e-03 | 2.832 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.567426e-03 | 2.805 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.798483e-03 | 2.745 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.191156e-03 | 2.659 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.777666e-03 | 2.556 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.968580e-03 | 2.527 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.190482e-03 | 2.496 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.641005e-03 | 2.439 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.576002e-03 | 2.447 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.647177e-03 | 2.438 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.526980e-03 | 2.453 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.876753e-03 | 2.412 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.965326e-03 | 2.402 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.028241e-03 | 2.395 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.513571e-03 | 2.345 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.636452e-03 | 2.334 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.153965e-03 | 2.211 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.153965e-03 | 2.211 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.153965e-03 | 2.211 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.153965e-03 | 2.211 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.291942e-03 | 2.276 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.554404e-03 | 2.255 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.056383e-03 | 2.218 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.699251e-03 | 2.244 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.117481e-03 | 2.291 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.394653e-03 | 2.268 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.467440e-03 | 2.189 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.603427e-03 | 2.180 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.337721e-03 | 2.134 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.103408e-03 | 2.149 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.336729e-03 | 2.134 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.784399e-03 | 2.109 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.859985e-03 | 2.105 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.859985e-03 | 2.105 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.892377e-03 | 2.103 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.825769e-03 | 2.106 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.552988e-03 | 2.068 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.940326e-03 | 2.003 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.940326e-03 | 2.003 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.980195e-03 | 2.001 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.057641e-02 | 1.976 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.090387e-02 | 1.962 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.124277e-02 | 1.949 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.133651e-02 | 1.946 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.249301e-02 | 1.903 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.205775e-02 | 1.919 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.205775e-02 | 1.919 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.306368e-02 | 1.884 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.360611e-02 | 1.866 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.360611e-02 | 1.866 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.362776e-02 | 1.866 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.423667e-02 | 1.847 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.441051e-02 | 1.841 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.618628e-02 | 1.791 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.646060e-02 | 1.784 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.817811e-02 | 1.740 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.735783e-02 | 1.761 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.817811e-02 | 1.740 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.796181e-02 | 1.746 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.753351e-02 | 1.756 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.827872e-02 | 1.738 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.831042e-02 | 1.737 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.022800e-02 | 1.694 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.895041e-02 | 1.722 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.892681e-02 | 1.723 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.909049e-02 | 1.719 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.022800e-02 | 1.694 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.022800e-02 | 1.694 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.905734e-02 | 1.720 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.023920e-02 | 1.694 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.153405e-02 | 1.667 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.153405e-02 | 1.667 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.163233e-02 | 1.665 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.174366e-02 | 1.663 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.416523e-02 | 1.617 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.421794e-02 | 1.616 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.438954e-02 | 1.613 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.476000e-02 | 1.606 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.535892e-02 | 1.596 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.875359e-02 | 1.541 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.876279e-02 | 1.541 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.678173e-02 | 1.572 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.824362e-02 | 1.549 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.652850e-02 | 1.576 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.876279e-02 | 1.541 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.750430e-02 | 1.561 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.677763e-02 | 1.572 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.885188e-02 | 1.540 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.888148e-02 | 1.539 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.888148e-02 | 1.539 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.888148e-02 | 1.539 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.888148e-02 | 1.539 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.888148e-02 | 1.539 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.959666e-02 | 1.529 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.982536e-02 | 1.525 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.262469e-02 | 1.486 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.262469e-02 | 1.486 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.161119e-02 | 1.500 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.121655e-02 | 1.506 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.088873e-02 | 1.510 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.378331e-02 | 1.471 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.378622e-02 | 1.471 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.487082e-02 | 1.458 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.523395e-02 | 1.453 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.584962e-02 | 1.446 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.729406e-02 | 1.428 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.776313e-02 | 1.423 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.779926e-02 | 1.423 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.850491e-02 | 1.414 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.930067e-02 | 1.406 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.935568e-02 | 1.405 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.049023e-02 | 1.393 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.069300e-02 | 1.390 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.135640e-02 | 1.383 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.137517e-02 | 1.383 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.547548e-02 | 1.342 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.515009e-02 | 1.345 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.628300e-02 | 1.335 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.957710e-02 | 1.305 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.957710e-02 | 1.305 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.976428e-02 | 1.303 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.003986e-02 | 1.301 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.102147e-02 | 1.292 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.102147e-02 | 1.292 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.102147e-02 | 1.292 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.215565e-02 | 1.283 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.215565e-02 | 1.283 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.215565e-02 | 1.283 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.231357e-02 | 1.281 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.046341e-02 | 1.219 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.046341e-02 | 1.219 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.940271e-02 | 1.226 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.573052e-02 | 1.254 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.573052e-02 | 1.254 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.491112e-02 | 1.260 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.303500e-02 | 1.275 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.805703e-02 | 1.236 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.585588e-02 | 1.253 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.046341e-02 | 1.219 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.591093e-02 | 1.253 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.581109e-02 | 1.253 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.409113e-02 | 1.267 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.046341e-02 | 1.219 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.303500e-02 | 1.275 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.166971e-02 | 1.210 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.177427e-02 | 1.209 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.253004e-02 | 1.204 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.284955e-02 | 1.202 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.434918e-02 | 1.191 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.472927e-02 | 1.189 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.472927e-02 | 1.189 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 7.708937e-02 | 1.113 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 7.708937e-02 | 1.113 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 7.708937e-02 | 1.113 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.940331e-02 | 1.159 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.641273e-02 | 1.117 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.644991e-02 | 1.178 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.517762e-02 | 1.124 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.560618e-02 | 1.121 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.644991e-02 | 1.178 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.940331e-02 | 1.159 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.940331e-02 | 1.159 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.708937e-02 | 1.113 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.173862e-02 | 1.144 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.498350e-02 | 1.125 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.722474e-02 | 1.172 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.692709e-02 | 1.114 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.722474e-02 | 1.172 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.705580e-02 | 1.174 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.260057e-02 | 1.139 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.075327e-02 | 1.093 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.075327e-02 | 1.093 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.075327e-02 | 1.093 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.075327e-02 | 1.093 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.130172e-02 | 1.090 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.266060e-02 | 1.083 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.365258e-02 | 1.078 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.488626e-02 | 1.071 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.713381e-02 | 1.060 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.713381e-02 | 1.060 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.713381e-02 | 1.060 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.826130e-02 | 1.054 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.047436e-01 | 0.980 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.047436e-01 | 0.980 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.830218e-02 | 1.007 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.830218e-02 | 1.007 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.793496e-02 | 1.009 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.035571e-01 | 0.985 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.454203e-02 | 1.024 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.454203e-02 | 1.024 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.934568e-02 | 1.003 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.344567e-02 | 1.029 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.922847e-02 | 1.049 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.041287e-01 | 0.982 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.111670e-02 | 1.040 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.786212e-02 | 1.009 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.907710e-02 | 1.050 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.111670e-02 | 1.040 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.793496e-02 | 1.009 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.830218e-02 | 1.007 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 9.830218e-02 | 1.007 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.906041e-02 | 1.004 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.201189e-02 | 1.036 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.786212e-02 | 1.009 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.793496e-02 | 1.009 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 9.830218e-02 | 1.007 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.793496e-02 | 1.009 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.064363e-01 | 0.973 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.406925e-02 | 1.027 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.064611e-01 | 0.973 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.073658e-01 | 0.969 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.077364e-01 | 0.968 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.104840e-01 | 0.957 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.666800e-01 | 0.778 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.666800e-01 | 0.778 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.666800e-01 | 0.778 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.666800e-01 | 0.778 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.666800e-01 | 0.778 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.666800e-01 | 0.778 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.666800e-01 | 0.778 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.666800e-01 | 0.778 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.666800e-01 | 0.778 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.666800e-01 | 0.778 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.392990e-01 | 0.621 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.392990e-01 | 0.621 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.392990e-01 | 0.621 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.392990e-01 | 0.621 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.392990e-01 | 0.621 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.345872e-01 | 0.871 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 1.345872e-01 | 0.871 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 1.345872e-01 | 0.871 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 1.660293e-01 | 0.780 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.660293e-01 | 0.780 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.055936e-01 | 0.515 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.055936e-01 | 0.515 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 3.055936e-01 | 0.515 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.055936e-01 | 0.515 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.172316e-01 | 0.931 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.985654e-01 | 0.702 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.317663e-01 | 0.635 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.317663e-01 | 0.635 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.317663e-01 | 0.635 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.317663e-01 | 0.635 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.317663e-01 | 0.635 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.661142e-01 | 0.436 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.661142e-01 | 0.436 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.661142e-01 | 0.436 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.661142e-01 | 0.436 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.661142e-01 | 0.436 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.661142e-01 | 0.436 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.661142e-01 | 0.436 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.661142e-01 | 0.436 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.661142e-01 | 0.436 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.276524e-01 | 0.894 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.807708e-01 | 0.743 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.807708e-01 | 0.743 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.157814e-01 | 0.936 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.036863e-01 | 0.691 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.606218e-01 | 0.794 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.606218e-01 | 0.794 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.987705e-01 | 0.525 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.987705e-01 | 0.525 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.213635e-01 | 0.375 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 4.213635e-01 | 0.375 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.213635e-01 | 0.375 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.213635e-01 | 0.375 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 4.213635e-01 | 0.375 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.213635e-01 | 0.375 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.213635e-01 | 0.375 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.213635e-01 | 0.375 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.962999e-01 | 0.707 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.374550e-01 | 0.862 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.512314e-01 | 0.600 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.320154e-01 | 0.479 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.320154e-01 | 0.479 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.320154e-01 | 0.479 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.859759e-01 | 0.731 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.341104e-01 | 0.631 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.750985e-01 | 0.757 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.644478e-01 | 0.784 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.647947e-01 | 0.438 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.647947e-01 | 0.438 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.647947e-01 | 0.438 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.647947e-01 | 0.438 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.718002e-01 | 0.326 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.718002e-01 | 0.326 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.718002e-01 | 0.326 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.718002e-01 | 0.326 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.718002e-01 | 0.326 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.636830e-01 | 0.786 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.636830e-01 | 0.786 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.969371e-01 | 0.401 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 3.969371e-01 | 0.401 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.969371e-01 | 0.401 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.969371e-01 | 0.401 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.969371e-01 | 0.401 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.977579e-01 | 0.704 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.456085e-01 | 0.610 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.495102e-01 | 0.457 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 3.495102e-01 | 0.457 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.263582e-01 | 0.645 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.396148e-01 | 0.620 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.211723e-01 | 0.655 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.332478e-01 | 0.632 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.023957e-01 | 0.519 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.740817e-01 | 0.427 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.283047e-01 | 0.368 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.283047e-01 | 0.368 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.283047e-01 | 0.368 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.283047e-01 | 0.368 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.283047e-01 | 0.368 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.283047e-01 | 0.368 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.178434e-01 | 0.286 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.178434e-01 | 0.286 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.178434e-01 | 0.286 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.178434e-01 | 0.286 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.178434e-01 | 0.286 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.178434e-01 | 0.286 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.913033e-01 | 0.536 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.546482e-01 | 0.450 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.984633e-01 | 0.400 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.984633e-01 | 0.400 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.984633e-01 | 0.400 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.984633e-01 | 0.400 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.169999e-01 | 0.664 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.587886e-01 | 0.338 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.090685e-01 | 0.510 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.225759e-01 | 0.374 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.234340e-01 | 0.490 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.234340e-01 | 0.490 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.954577e-01 | 0.403 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.954577e-01 | 0.403 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.544784e-01 | 0.450 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.544784e-01 | 0.450 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.469847e-01 | 0.607 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.469847e-01 | 0.607 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.157238e-01 | 0.381 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.883045e-01 | 0.311 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.598755e-01 | 0.252 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.598755e-01 | 0.252 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.075586e-01 | 0.512 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.670720e-01 | 0.435 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.697208e-01 | 0.328 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.697208e-01 | 0.328 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.697208e-01 | 0.328 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.557416e-01 | 0.341 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.167897e-01 | 0.287 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.167897e-01 | 0.287 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.167897e-01 | 0.287 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.167897e-01 | 0.287 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.634216e-01 | 0.440 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.926368e-01 | 0.307 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.754092e-01 | 0.323 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.025757e-01 | 0.395 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.150506e-01 | 0.288 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.150506e-01 | 0.288 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.441994e-01 | 0.264 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.441994e-01 | 0.264 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.441994e-01 | 0.264 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.441994e-01 | 0.264 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.584826e-01 | 0.339 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.693189e-01 | 0.329 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.693189e-01 | 0.329 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.138796e-01 | 0.289 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.369228e-01 | 0.270 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.369228e-01 | 0.270 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.369228e-01 | 0.270 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.369228e-01 | 0.270 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.369228e-01 | 0.270 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.661277e-01 | 0.331 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.852995e-01 | 0.314 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.124993e-01 | 0.290 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.120748e-01 | 0.291 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.582204e-01 | 0.253 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.509944e-01 | 0.259 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.238064e-01 | 0.281 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.398970e-01 | 0.268 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.564021e-01 | 0.255 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.644478e-01 | 0.784 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.678255e-01 | 0.434 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.495525e-01 | 0.825 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.495102e-01 | 0.457 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.172316e-01 | 0.931 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.804271e-01 | 0.744 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.427179e-01 | 0.265 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.811967e-01 | 0.742 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.544784e-01 | 0.450 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.006572e-01 | 0.698 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.509944e-01 | 0.259 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.987705e-01 | 0.525 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.562263e-01 | 0.806 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.880317e-01 | 0.726 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.756565e-01 | 0.425 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.586212e-01 | 0.800 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.157814e-01 | 0.936 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.006572e-01 | 0.698 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.133652e-01 | 0.671 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.973211e-01 | 0.527 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.883045e-01 | 0.311 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.652695e-01 | 0.576 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.987705e-01 | 0.525 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.001605e-01 | 0.523 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.342107e-01 | 0.476 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.966351e-01 | 0.528 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.225759e-01 | 0.374 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.234340e-01 | 0.490 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.852995e-01 | 0.314 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.130748e-01 | 0.290 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.130748e-01 | 0.290 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.138796e-01 | 0.289 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.962999e-01 | 0.707 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.374550e-01 | 0.862 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.320154e-01 | 0.479 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.536336e-01 | 0.596 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.636830e-01 | 0.786 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.473794e-01 | 0.832 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.984633e-01 | 0.400 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.751373e-01 | 0.560 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.660467e-01 | 0.332 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.979447e-01 | 0.303 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.606218e-01 | 0.794 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.498996e-01 | 0.456 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.987705e-01 | 0.525 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.426022e-01 | 0.266 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.157238e-01 | 0.381 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.364419e-01 | 0.473 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.213635e-01 | 0.375 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.718002e-01 | 0.326 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.093370e-01 | 0.679 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.155147e-01 | 0.937 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.587886e-01 | 0.338 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.225759e-01 | 0.374 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.858194e-01 | 0.544 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.463491e-01 | 0.350 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.314128e-01 | 0.365 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.314128e-01 | 0.365 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.138796e-01 | 0.289 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.750985e-01 | 0.757 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.536336e-01 | 0.596 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.729679e-01 | 0.762 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.342107e-01 | 0.476 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.237918e-01 | 0.650 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.529020e-01 | 0.816 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.225759e-01 | 0.374 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.130748e-01 | 0.290 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.436462e-01 | 0.843 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.319095e-01 | 0.365 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.164068e-01 | 0.665 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.442848e-01 | 0.352 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.719297e-01 | 0.326 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.589799e-01 | 0.799 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.374550e-01 | 0.862 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.718002e-01 | 0.326 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.718002e-01 | 0.326 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.718002e-01 | 0.326 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.339663e-01 | 0.631 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.368320e-01 | 0.864 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.758603e-01 | 0.559 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.283047e-01 | 0.368 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.100430e-01 | 0.678 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.263302e-01 | 0.645 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.161306e-01 | 0.665 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.591405e-01 | 0.445 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.442848e-01 | 0.352 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.344350e-01 | 0.362 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.754092e-01 | 0.323 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.502912e-01 | 0.347 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.790618e-01 | 0.320 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.138796e-01 | 0.289 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.584826e-01 | 0.339 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.021430e-01 | 0.520 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.583769e-01 | 0.446 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.461355e-01 | 0.263 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.326199e-01 | 0.274 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.947995e-01 | 0.306 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.755865e-01 | 0.560 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.718002e-01 | 0.326 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.095986e-01 | 0.509 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.157238e-01 | 0.381 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.509944e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.257089e-01 | 0.371 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.257089e-01 | 0.371 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.257089e-01 | 0.371 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.257089e-01 | 0.371 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.557598e-01 | 0.592 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.218700e-01 | 0.492 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.509944e-01 | 0.259 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.660293e-01 | 0.780 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.807708e-01 | 0.743 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.807708e-01 | 0.743 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.807708e-01 | 0.743 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.213635e-01 | 0.375 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.213635e-01 | 0.375 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.213635e-01 | 0.375 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 4.718002e-01 | 0.326 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.718002e-01 | 0.326 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.647092e-01 | 0.783 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.740817e-01 | 0.427 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.598755e-01 | 0.252 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.747766e-01 | 0.426 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.025125e-01 | 0.395 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.240206e-01 | 0.373 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.509944e-01 | 0.259 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.200818e-01 | 0.921 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.345872e-01 | 0.871 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.985654e-01 | 0.702 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.708485e-01 | 0.767 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.463388e-01 | 0.835 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.332478e-01 | 0.632 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.226703e-01 | 0.491 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.314128e-01 | 0.365 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.434355e-01 | 0.353 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.507831e-01 | 0.822 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.441994e-01 | 0.264 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.120748e-01 | 0.291 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.372388e-01 | 0.625 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.175691e-01 | 0.930 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.754092e-01 | 0.323 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.530799e-01 | 0.815 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.531129e-01 | 0.597 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.297347e-01 | 0.276 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.403121e-01 | 0.356 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.125118e-01 | 0.949 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.250051e-01 | 0.488 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.441994e-01 | 0.264 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.806387e-01 | 0.318 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.392990e-01 | 0.621 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.392990e-01 | 0.621 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.660293e-01 | 0.780 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.055936e-01 | 0.515 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.055936e-01 | 0.515 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.123555e-01 | 0.949 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.661142e-01 | 0.436 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.661142e-01 | 0.436 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.036863e-01 | 0.691 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.213635e-01 | 0.375 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.621084e-01 | 0.790 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 3.647947e-01 | 0.438 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.647947e-01 | 0.438 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.718002e-01 | 0.326 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.543025e-01 | 0.812 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.543025e-01 | 0.812 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.164068e-01 | 0.665 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.506864e-01 | 0.601 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.935604e-01 | 0.532 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.969371e-01 | 0.401 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.969371e-01 | 0.401 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.133652e-01 | 0.671 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.495102e-01 | 0.457 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.178434e-01 | 0.286 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.178434e-01 | 0.286 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.178434e-01 | 0.286 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.178434e-01 | 0.286 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.966351e-01 | 0.528 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.009045e-01 | 0.697 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.544784e-01 | 0.450 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.598755e-01 | 0.252 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.598755e-01 | 0.252 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.358330e-01 | 0.361 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.167897e-01 | 0.287 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.582204e-01 | 0.253 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.774682e-01 | 0.321 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.456085e-01 | 0.610 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.357269e-01 | 0.867 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.308464e-01 | 0.366 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.342107e-01 | 0.476 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.582204e-01 | 0.253 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.124019e-01 | 0.949 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.942890e-01 | 0.712 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.149751e-01 | 0.668 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.314997e-01 | 0.881 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.266772e-01 | 0.370 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.587886e-01 | 0.338 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.531129e-01 | 0.597 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.217795e-01 | 0.914 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.059280e-01 | 0.686 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.386770e-01 | 0.269 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.807708e-01 | 0.743 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.437634e-01 | 0.842 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.954577e-01 | 0.403 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.719297e-01 | 0.326 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.590311e-01 | 0.445 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.548547e-01 | 0.342 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.172316e-01 | 0.931 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 1.276524e-01 | 0.894 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.320154e-01 | 0.479 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.709408e-01 | 0.767 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.220312e-01 | 0.654 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.864951e-01 | 0.413 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.150506e-01 | 0.288 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.851342e-01 | 0.733 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.047808e-01 | 0.689 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.003537e-01 | 0.522 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.442848e-01 | 0.352 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 4.587886e-01 | 0.338 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.733497e-01 | 0.428 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.344702e-01 | 0.476 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.167897e-01 | 0.287 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.260635e-01 | 0.279 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.257089e-01 | 0.371 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.358330e-01 | 0.361 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.831118e-01 | 0.737 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.219865e-01 | 0.492 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.314128e-01 | 0.365 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.317663e-01 | 0.635 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.317663e-01 | 0.635 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.213635e-01 | 0.375 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.250817e-01 | 0.903 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.750985e-01 | 0.757 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.283047e-01 | 0.368 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.555198e-01 | 0.449 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.697208e-01 | 0.328 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.737426e-01 | 0.563 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.449722e-01 | 0.352 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.548547e-01 | 0.342 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.441994e-01 | 0.264 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.441994e-01 | 0.264 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.297347e-01 | 0.276 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.087678e-01 | 0.680 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.449722e-01 | 0.352 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.704747e-01 | 0.431 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.036863e-01 | 0.691 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.558005e-01 | 0.592 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.357269e-01 | 0.867 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.069533e-01 | 0.390 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.147237e-01 | 0.940 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.198013e-01 | 0.922 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.740817e-01 | 0.427 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.441994e-01 | 0.264 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.326199e-01 | 0.274 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.270527e-01 | 0.485 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.047808e-01 | 0.689 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.047808e-01 | 0.689 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.342107e-01 | 0.476 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.548547e-01 | 0.342 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.926368e-01 | 0.307 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.543375e-01 | 0.343 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.660293e-01 | 0.780 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.172316e-01 | 0.931 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.661142e-01 | 0.436 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.213635e-01 | 0.375 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.512314e-01 | 0.600 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.512314e-01 | 0.600 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.755865e-01 | 0.560 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 2.755865e-01 | 0.560 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.647947e-01 | 0.438 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.718002e-01 | 0.326 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.676941e-01 | 0.572 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.606185e-01 | 0.584 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.758603e-01 | 0.559 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.178434e-01 | 0.286 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.377244e-01 | 0.471 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.377244e-01 | 0.471 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.598755e-01 | 0.252 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.598755e-01 | 0.252 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.557416e-01 | 0.341 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.617558e-01 | 0.336 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.548547e-01 | 0.342 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.947995e-01 | 0.306 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.222763e-01 | 0.282 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.385340e-01 | 0.470 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.441994e-01 | 0.264 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.975878e-01 | 0.401 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.429842e-01 | 0.845 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.984633e-01 | 0.400 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.185008e-01 | 0.378 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 5.582204e-01 | 0.253 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.512314e-01 | 0.600 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.859759e-01 | 0.731 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.647947e-01 | 0.438 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.647947e-01 | 0.438 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.339663e-01 | 0.631 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.456085e-01 | 0.610 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.097918e-01 | 0.509 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.598755e-01 | 0.252 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.089636e-01 | 0.388 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.433394e-01 | 0.353 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.966351e-01 | 0.528 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.984633e-01 | 0.400 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.544784e-01 | 0.450 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.544784e-01 | 0.450 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.157238e-01 | 0.381 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.707670e-01 | 0.431 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.238064e-01 | 0.281 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.740817e-01 | 0.427 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.502912e-01 | 0.347 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.185008e-01 | 0.378 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.319095e-01 | 0.365 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.463564e-01 | 0.835 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.437634e-01 | 0.842 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.718002e-01 | 0.326 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.718002e-01 | 0.326 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.283047e-01 | 0.368 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.283047e-01 | 0.368 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.587886e-01 | 0.338 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.555198e-01 | 0.449 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.954577e-01 | 0.403 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.733497e-01 | 0.428 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.733497e-01 | 0.428 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.598755e-01 | 0.252 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.167897e-01 | 0.287 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 4.926368e-01 | 0.307 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.441994e-01 | 0.264 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.509944e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.124993e-01 | 0.290 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.456085e-01 | 0.610 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.961763e-01 | 0.304 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.138796e-01 | 0.289 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.849451e-01 | 0.545 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.606185e-01 | 0.584 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.442848e-01 | 0.352 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.718002e-01 | 0.326 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.734733e-01 | 0.563 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.248374e-01 | 0.488 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.023957e-01 | 0.519 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.178434e-01 | 0.286 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.178434e-01 | 0.286 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.178434e-01 | 0.286 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.178434e-01 | 0.286 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.377244e-01 | 0.471 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.225759e-01 | 0.374 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.598755e-01 | 0.252 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.598755e-01 | 0.252 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.060256e-01 | 0.514 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.167897e-01 | 0.287 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.617558e-01 | 0.336 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 5.598755e-01 | 0.252 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.606218e-01 | 0.794 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.341104e-01 | 0.631 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.740821e-01 | 0.324 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.447062e-01 | 0.463 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.495525e-01 | 0.825 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.178434e-01 | 0.286 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.750821e-01 | 0.426 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.441994e-01 | 0.264 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.555198e-01 | 0.449 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.647947e-01 | 0.438 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.977579e-01 | 0.704 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.163325e-01 | 0.665 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.373897e-01 | 0.862 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.178434e-01 | 0.286 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.670720e-01 | 0.435 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.442848e-01 | 0.352 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.297347e-01 | 0.276 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.922255e-01 | 0.534 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.320154e-01 | 0.479 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.966351e-01 | 0.528 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.442848e-01 | 0.352 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.369228e-01 | 0.270 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.297347e-01 | 0.276 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.622586e-01 | 0.250 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.622586e-01 | 0.250 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.670487e-01 | 0.246 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.705049e-01 | 0.244 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.705049e-01 | 0.244 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.705049e-01 | 0.244 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.705049e-01 | 0.244 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.736418e-01 | 0.241 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.783723e-01 | 0.238 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.789166e-01 | 0.237 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.789166e-01 | 0.237 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.789166e-01 | 0.237 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.789166e-01 | 0.237 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.789166e-01 | 0.237 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.807427e-01 | 0.236 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.860500e-01 | 0.232 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.865575e-01 | 0.232 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.865575e-01 | 0.232 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.952824e-01 | 0.225 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.956904e-01 | 0.225 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.956904e-01 | 0.225 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.956904e-01 | 0.225 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.956904e-01 | 0.225 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.956904e-01 | 0.225 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.956904e-01 | 0.225 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.956904e-01 | 0.225 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.956904e-01 | 0.225 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.956904e-01 | 0.225 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.956904e-01 | 0.225 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.982457e-01 | 0.223 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.982457e-01 | 0.223 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.982457e-01 | 0.223 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.982457e-01 | 0.223 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.982457e-01 | 0.223 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.982457e-01 | 0.223 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.982457e-01 | 0.223 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.982457e-01 | 0.223 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.982457e-01 | 0.223 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.982457e-01 | 0.223 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.982457e-01 | 0.223 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.001605e-01 | 0.222 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.114682e-01 | 0.214 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.123030e-01 | 0.213 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.123030e-01 | 0.213 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.178633e-01 | 0.209 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.184253e-01 | 0.209 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.184253e-01 | 0.209 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.184253e-01 | 0.209 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.197511e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.197511e-01 | 0.208 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.197511e-01 | 0.208 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.197511e-01 | 0.208 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.197511e-01 | 0.208 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.197511e-01 | 0.208 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.197511e-01 | 0.208 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.197511e-01 | 0.208 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.204221e-01 | 0.207 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.204221e-01 | 0.207 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.236666e-01 | 0.205 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.239082e-01 | 0.205 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.239082e-01 | 0.205 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.245139e-01 | 0.204 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.301896e-01 | 0.201 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.314278e-01 | 0.200 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.332729e-01 | 0.198 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.332729e-01 | 0.198 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.332729e-01 | 0.198 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.332729e-01 | 0.198 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.332729e-01 | 0.198 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.332729e-01 | 0.198 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.332729e-01 | 0.198 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.332729e-01 | 0.198 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.332729e-01 | 0.198 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.332729e-01 | 0.198 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.332729e-01 | 0.198 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.332729e-01 | 0.198 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.332729e-01 | 0.198 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.332729e-01 | 0.198 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.332729e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.333067e-01 | 0.198 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.354922e-01 | 0.197 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.372103e-01 | 0.196 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.381861e-01 | 0.195 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.381861e-01 | 0.195 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.381861e-01 | 0.195 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.406593e-01 | 0.193 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.426917e-01 | 0.192 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.426917e-01 | 0.192 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.426917e-01 | 0.192 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.426917e-01 | 0.192 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.426917e-01 | 0.192 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.426917e-01 | 0.192 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.426917e-01 | 0.192 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.426917e-01 | 0.192 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.426917e-01 | 0.192 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.468750e-01 | 0.189 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.475402e-01 | 0.189 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.514287e-01 | 0.186 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.523540e-01 | 0.186 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.524860e-01 | 0.185 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.524860e-01 | 0.185 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.524860e-01 | 0.185 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.524860e-01 | 0.185 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.524860e-01 | 0.185 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.524860e-01 | 0.185 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.535970e-01 | 0.185 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.536923e-01 | 0.185 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.536923e-01 | 0.185 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.544032e-01 | 0.184 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.553380e-01 | 0.184 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.571494e-01 | 0.182 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.589693e-01 | 0.181 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.607675e-01 | 0.180 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.645247e-01 | 0.177 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.645247e-01 | 0.177 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.652480e-01 | 0.177 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.652480e-01 | 0.177 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.652480e-01 | 0.177 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.652480e-01 | 0.177 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.652480e-01 | 0.177 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.652480e-01 | 0.177 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.652480e-01 | 0.177 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.652480e-01 | 0.177 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.652480e-01 | 0.177 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.652480e-01 | 0.177 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.652480e-01 | 0.177 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.652480e-01 | 0.177 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.652480e-01 | 0.177 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.661635e-01 | 0.176 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.661917e-01 | 0.176 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.673251e-01 | 0.176 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.678217e-01 | 0.175 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.678217e-01 | 0.175 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.678217e-01 | 0.175 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.710967e-01 | 0.173 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.728051e-01 | 0.172 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.785959e-01 | 0.168 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.796094e-01 | 0.168 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.826864e-01 | 0.166 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.838967e-01 | 0.165 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.852687e-01 | 0.164 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.852687e-01 | 0.164 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.852687e-01 | 0.164 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.852687e-01 | 0.164 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.852687e-01 | 0.164 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.896117e-01 | 0.161 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.896117e-01 | 0.161 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.896117e-01 | 0.161 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.896117e-01 | 0.161 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.896117e-01 | 0.161 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.896117e-01 | 0.161 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.896117e-01 | 0.161 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.900218e-01 | 0.161 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.906482e-01 | 0.161 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.911840e-01 | 0.160 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.926879e-01 | 0.159 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.944370e-01 | 0.158 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.944370e-01 | 0.158 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.944370e-01 | 0.158 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.944370e-01 | 0.158 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.944370e-01 | 0.158 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.944370e-01 | 0.158 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.944370e-01 | 0.158 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.944370e-01 | 0.158 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 6.944370e-01 | 0.158 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.944370e-01 | 0.158 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.944370e-01 | 0.158 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.944370e-01 | 0.158 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.944370e-01 | 0.158 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.944370e-01 | 0.158 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.944370e-01 | 0.158 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.999175e-01 | 0.155 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.009882e-01 | 0.154 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.029253e-01 | 0.153 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.049476e-01 | 0.152 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.049476e-01 | 0.152 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.049476e-01 | 0.152 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.049476e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.049476e-01 | 0.152 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.057608e-01 | 0.151 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.057608e-01 | 0.151 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.108455e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.109946e-01 | 0.148 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.109946e-01 | 0.148 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.109946e-01 | 0.148 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.131402e-01 | 0.147 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.138427e-01 | 0.146 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.154436e-01 | 0.145 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.177328e-01 | 0.144 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.210824e-01 | 0.142 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.210824e-01 | 0.142 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.210824e-01 | 0.142 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.210824e-01 | 0.142 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.210824e-01 | 0.142 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.210824e-01 | 0.142 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.210824e-01 | 0.142 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.212582e-01 | 0.142 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.212582e-01 | 0.142 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.212582e-01 | 0.142 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.212582e-01 | 0.142 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.221450e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.235895e-01 | 0.141 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.235895e-01 | 0.141 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.235895e-01 | 0.141 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.235895e-01 | 0.141 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.244382e-01 | 0.140 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.296975e-01 | 0.137 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.296975e-01 | 0.137 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.304638e-01 | 0.136 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.361120e-01 | 0.133 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.361120e-01 | 0.133 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.386893e-01 | 0.132 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.412255e-01 | 0.130 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.412255e-01 | 0.130 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.412255e-01 | 0.130 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.412255e-01 | 0.130 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.412255e-01 | 0.130 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.412908e-01 | 0.130 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.422580e-01 | 0.129 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.422580e-01 | 0.129 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.445783e-01 | 0.128 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.454058e-01 | 0.128 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.454058e-01 | 0.128 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.454058e-01 | 0.128 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.454058e-01 | 0.128 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.454058e-01 | 0.128 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.454058e-01 | 0.128 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.454058e-01 | 0.128 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.454058e-01 | 0.128 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.454058e-01 | 0.128 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.454058e-01 | 0.128 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.454058e-01 | 0.128 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.454058e-01 | 0.128 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.454058e-01 | 0.128 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.454058e-01 | 0.128 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.499164e-01 | 0.125 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.499164e-01 | 0.125 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.499164e-01 | 0.125 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.503322e-01 | 0.125 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.503322e-01 | 0.125 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.525145e-01 | 0.123 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.577309e-01 | 0.120 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.578891e-01 | 0.120 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.578891e-01 | 0.120 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.578891e-01 | 0.120 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.578891e-01 | 0.120 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.611551e-01 | 0.119 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.619597e-01 | 0.118 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.619597e-01 | 0.118 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.639308e-01 | 0.117 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.676093e-01 | 0.115 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.676093e-01 | 0.115 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.676093e-01 | 0.115 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.676093e-01 | 0.115 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.676093e-01 | 0.115 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.676093e-01 | 0.115 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.676093e-01 | 0.115 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.676093e-01 | 0.115 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.676093e-01 | 0.115 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.678064e-01 | 0.115 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.721837e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.736160e-01 | 0.111 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.736160e-01 | 0.111 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.736160e-01 | 0.111 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.736160e-01 | 0.111 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.736160e-01 | 0.111 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.738633e-01 | 0.111 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.760810e-01 | 0.110 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.769211e-01 | 0.110 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.769211e-01 | 0.110 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.793483e-01 | 0.108 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.796783e-01 | 0.108 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.843702e-01 | 0.105 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.853918e-01 | 0.105 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.878776e-01 | 0.104 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.878776e-01 | 0.104 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.878776e-01 | 0.104 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.878776e-01 | 0.104 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.878776e-01 | 0.104 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.878776e-01 | 0.104 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.878776e-01 | 0.104 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.878776e-01 | 0.104 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.878776e-01 | 0.104 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.879732e-01 | 0.103 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.884426e-01 | 0.103 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.884426e-01 | 0.103 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.884426e-01 | 0.103 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.884426e-01 | 0.103 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.912542e-01 | 0.102 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.944054e-01 | 0.100 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.953829e-01 | 0.099 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.963428e-01 | 0.099 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.011362e-01 | 0.096 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.011362e-01 | 0.096 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.011362e-01 | 0.096 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.011362e-01 | 0.096 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.011362e-01 | 0.096 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.024063e-01 | 0.096 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.024063e-01 | 0.096 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.024063e-01 | 0.096 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.024063e-01 | 0.096 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.024063e-01 | 0.096 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.024063e-01 | 0.096 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.031252e-01 | 0.095 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.044594e-01 | 0.094 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.052331e-01 | 0.094 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.063793e-01 | 0.093 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.063793e-01 | 0.093 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.063793e-01 | 0.093 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.063793e-01 | 0.093 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.063793e-01 | 0.093 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.063793e-01 | 0.093 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.063793e-01 | 0.093 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.063793e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.063793e-01 | 0.093 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.063793e-01 | 0.093 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.063793e-01 | 0.093 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.063793e-01 | 0.093 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.063793e-01 | 0.093 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.063793e-01 | 0.093 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.066674e-01 | 0.093 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.066674e-01 | 0.093 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.094306e-01 | 0.092 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.115551e-01 | 0.091 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.122823e-01 | 0.090 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.123932e-01 | 0.090 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.155448e-01 | 0.089 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.155448e-01 | 0.089 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.155448e-01 | 0.089 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.155448e-01 | 0.089 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.155448e-01 | 0.089 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.155448e-01 | 0.089 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.196994e-01 | 0.086 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.210267e-01 | 0.086 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.212019e-01 | 0.086 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.221105e-01 | 0.085 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.232683e-01 | 0.084 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.232683e-01 | 0.084 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.232683e-01 | 0.084 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.232683e-01 | 0.084 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.232683e-01 | 0.084 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.232683e-01 | 0.084 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.232683e-01 | 0.084 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.232683e-01 | 0.084 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.232683e-01 | 0.084 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.278958e-01 | 0.082 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.278958e-01 | 0.082 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.278958e-01 | 0.082 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.278958e-01 | 0.082 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.278958e-01 | 0.082 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.332913e-01 | 0.079 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.332913e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.339459e-01 | 0.079 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.339459e-01 | 0.079 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.348779e-01 | 0.078 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.371911e-01 | 0.077 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.375281e-01 | 0.077 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.375281e-01 | 0.077 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.386849e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.386849e-01 | 0.076 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.386849e-01 | 0.076 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.386849e-01 | 0.076 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.386849e-01 | 0.076 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.386849e-01 | 0.076 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.386849e-01 | 0.076 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.386849e-01 | 0.076 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.394967e-01 | 0.076 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.394967e-01 | 0.076 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.394967e-01 | 0.076 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.394967e-01 | 0.076 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.421315e-01 | 0.075 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.429680e-01 | 0.074 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.434256e-01 | 0.074 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.483617e-01 | 0.071 | 0 | 0 |
| Translation | R-HSA-72766 | 8.498541e-01 | 0.071 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.503842e-01 | 0.070 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.503842e-01 | 0.070 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.503842e-01 | 0.070 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.508338e-01 | 0.070 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.508338e-01 | 0.070 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.521540e-01 | 0.069 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.521540e-01 | 0.069 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.527576e-01 | 0.069 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.527576e-01 | 0.069 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.527576e-01 | 0.069 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.527576e-01 | 0.069 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.527576e-01 | 0.069 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.527576e-01 | 0.069 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.527576e-01 | 0.069 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.527576e-01 | 0.069 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.527576e-01 | 0.069 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.527576e-01 | 0.069 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.527576e-01 | 0.069 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.538348e-01 | 0.069 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.540474e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.540474e-01 | 0.069 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.556111e-01 | 0.068 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.602434e-01 | 0.065 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.605946e-01 | 0.065 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.606858e-01 | 0.065 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.654741e-01 | 0.063 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.654741e-01 | 0.063 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.656034e-01 | 0.063 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.656034e-01 | 0.063 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.656034e-01 | 0.063 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.656931e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.666850e-01 | 0.062 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.691269e-01 | 0.061 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.691269e-01 | 0.061 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.691336e-01 | 0.061 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.701631e-01 | 0.060 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.704351e-01 | 0.060 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.704351e-01 | 0.060 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.734217e-01 | 0.059 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.751058e-01 | 0.058 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.769501e-01 | 0.057 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.773292e-01 | 0.057 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.773292e-01 | 0.057 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.773292e-01 | 0.057 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.773292e-01 | 0.057 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.773292e-01 | 0.057 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.773292e-01 | 0.057 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.773292e-01 | 0.057 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.791240e-01 | 0.056 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.791240e-01 | 0.056 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.802651e-01 | 0.055 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.803271e-01 | 0.055 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.835801e-01 | 0.054 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.865724e-01 | 0.052 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.865724e-01 | 0.052 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.875103e-01 | 0.052 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.875103e-01 | 0.052 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.875103e-01 | 0.052 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.875103e-01 | 0.052 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.875103e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.880326e-01 | 0.052 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.880326e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.880326e-01 | 0.052 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.880326e-01 | 0.052 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.880326e-01 | 0.052 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.880326e-01 | 0.052 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.880326e-01 | 0.052 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.880326e-01 | 0.052 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.890957e-01 | 0.051 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.899301e-01 | 0.051 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.899301e-01 | 0.051 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.899301e-01 | 0.051 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.919302e-01 | 0.050 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.953542e-01 | 0.048 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.953542e-01 | 0.048 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.959303e-01 | 0.048 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.964012e-01 | 0.047 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.978026e-01 | 0.047 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.978026e-01 | 0.047 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.978026e-01 | 0.047 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.978026e-01 | 0.047 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.978026e-01 | 0.047 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.978026e-01 | 0.047 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.978026e-01 | 0.047 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.978026e-01 | 0.047 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.011399e-01 | 0.045 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.020010e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.022633e-01 | 0.045 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.026863e-01 | 0.044 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.050592e-01 | 0.043 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.062300e-01 | 0.043 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.067207e-01 | 0.043 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.067207e-01 | 0.043 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.067207e-01 | 0.043 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.067207e-01 | 0.043 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.067207e-01 | 0.043 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.067207e-01 | 0.043 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.088485e-01 | 0.042 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.094662e-01 | 0.041 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.095363e-01 | 0.041 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.112542e-01 | 0.040 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.116437e-01 | 0.040 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.145651e-01 | 0.039 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.148610e-01 | 0.039 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.148610e-01 | 0.039 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.148610e-01 | 0.039 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.148610e-01 | 0.039 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.156144e-01 | 0.038 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.159324e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.159324e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.159324e-01 | 0.038 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.196463e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.197443e-01 | 0.036 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.219016e-01 | 0.035 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.219016e-01 | 0.035 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.219016e-01 | 0.035 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.222914e-01 | 0.035 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.222914e-01 | 0.035 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.222914e-01 | 0.035 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.222914e-01 | 0.035 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.222914e-01 | 0.035 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.234067e-01 | 0.035 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.237103e-01 | 0.034 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.237103e-01 | 0.034 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.243742e-01 | 0.034 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.259335e-01 | 0.033 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.268834e-01 | 0.033 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.274698e-01 | 0.033 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.274698e-01 | 0.033 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.274698e-01 | 0.033 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.274698e-01 | 0.033 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.274698e-01 | 0.033 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.274698e-01 | 0.033 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.281696e-01 | 0.032 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.290737e-01 | 0.032 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.306260e-01 | 0.031 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.311369e-01 | 0.031 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.311369e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.311369e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.311369e-01 | 0.031 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.326614e-01 | 0.030 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.352645e-01 | 0.029 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.352645e-01 | 0.029 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.352645e-01 | 0.029 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.352645e-01 | 0.029 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.352645e-01 | 0.029 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.352645e-01 | 0.029 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.369562e-01 | 0.028 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.374997e-01 | 0.028 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.374997e-01 | 0.028 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.409152e-01 | 0.026 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.409152e-01 | 0.026 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.409152e-01 | 0.026 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.409152e-01 | 0.026 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.409152e-01 | 0.026 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.409152e-01 | 0.026 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.416707e-01 | 0.026 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.420069e-01 | 0.026 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.430318e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.438308e-01 | 0.025 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.460729e-01 | 0.024 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.460729e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.460729e-01 | 0.024 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.460729e-01 | 0.024 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.460729e-01 | 0.024 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.462037e-01 | 0.024 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.462037e-01 | 0.024 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.463928e-01 | 0.024 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.466931e-01 | 0.024 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.466931e-01 | 0.024 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.476614e-01 | 0.023 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.476614e-01 | 0.023 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.476614e-01 | 0.023 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.501102e-01 | 0.022 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.507807e-01 | 0.022 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.507807e-01 | 0.022 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.507807e-01 | 0.022 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.507807e-01 | 0.022 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.507807e-01 | 0.022 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.507807e-01 | 0.022 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.507807e-01 | 0.022 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.532133e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.532133e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.537449e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.544544e-01 | 0.020 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.550778e-01 | 0.020 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.550778e-01 | 0.020 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.550778e-01 | 0.020 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.550778e-01 | 0.020 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.550778e-01 | 0.020 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.550778e-01 | 0.020 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.565228e-01 | 0.019 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.571255e-01 | 0.019 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.571365e-01 | 0.019 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.590000e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.590000e-01 | 0.018 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.590000e-01 | 0.018 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.590000e-01 | 0.018 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.590000e-01 | 0.018 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.592544e-01 | 0.018 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.602687e-01 | 0.018 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.619740e-01 | 0.017 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.620018e-01 | 0.017 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.625799e-01 | 0.017 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.625799e-01 | 0.017 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.625799e-01 | 0.017 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.631901e-01 | 0.016 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.634663e-01 | 0.016 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.634839e-01 | 0.016 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.637944e-01 | 0.016 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.640476e-01 | 0.016 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.640996e-01 | 0.016 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.644381e-01 | 0.016 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.657020e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.658474e-01 | 0.015 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.658474e-01 | 0.015 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.658474e-01 | 0.015 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.659045e-01 | 0.015 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.670661e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.684258e-01 | 0.014 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.684308e-01 | 0.014 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.688298e-01 | 0.014 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.696271e-01 | 0.013 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.699243e-01 | 0.013 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.707669e-01 | 0.013 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.708908e-01 | 0.013 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.712460e-01 | 0.013 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.715519e-01 | 0.013 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.726418e-01 | 0.012 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.729401e-01 | 0.012 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.729972e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.739857e-01 | 0.011 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.740365e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.740365e-01 | 0.011 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.748093e-01 | 0.011 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.763041e-01 | 0.010 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.763041e-01 | 0.010 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.763041e-01 | 0.010 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.763041e-01 | 0.010 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.763041e-01 | 0.010 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.763041e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.783739e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.783739e-01 | 0.009 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.783739e-01 | 0.009 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.790564e-01 | 0.009 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.794200e-01 | 0.009 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.795772e-01 | 0.009 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.801726e-01 | 0.009 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.802419e-01 | 0.009 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.802630e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.802630e-01 | 0.009 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.802630e-01 | 0.009 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.802630e-01 | 0.009 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.818698e-01 | 0.008 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.819871e-01 | 0.008 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.819871e-01 | 0.008 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.819871e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.819871e-01 | 0.008 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.819871e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.822636e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.830759e-01 | 0.007 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.834766e-01 | 0.007 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.835608e-01 | 0.007 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.835608e-01 | 0.007 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.843280e-01 | 0.007 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.846100e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.846100e-01 | 0.007 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.849970e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.849970e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.851286e-01 | 0.007 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.853848e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.855147e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.855147e-01 | 0.006 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.859898e-01 | 0.006 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.863078e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.863078e-01 | 0.006 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.863078e-01 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.866137e-01 | 0.006 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.866137e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.875042e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.876314e-01 | 0.005 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.876314e-01 | 0.005 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.878382e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.885961e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.885961e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.885961e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.891283e-01 | 0.005 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.894455e-01 | 0.005 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.895927e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.895927e-01 | 0.005 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.895927e-01 | 0.005 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.905022e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.910611e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.913323e-01 | 0.004 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.913323e-01 | 0.004 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.913323e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.919540e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.923283e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.925204e-01 | 0.003 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.928804e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.939695e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.939695e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.939882e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.940224e-01 | 0.003 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.944359e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.949365e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.949934e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.951904e-01 | 0.002 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.952652e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.954312e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.954312e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.955341e-01 | 0.002 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.958307e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.958307e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.958540e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.961751e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.961953e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.965187e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.965280e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.967047e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.968436e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.971087e-01 | 0.001 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.971595e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.973184e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.974487e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.978030e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.981027e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.981952e-01 | 0.001 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.983307e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.983709e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.983709e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.984139e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990163e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.990214e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.991977e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.992158e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.992636e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993155e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.993905e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.993922e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.994855e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994925e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994940e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.995267e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996145e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.996612e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997410e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.997999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998118e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998270e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999042e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999192e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999260e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999448e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999548e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999554e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999733e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999752e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999752e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999896e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999907e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999910e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999926e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999926e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999927e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999949e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999959e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999964e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999966e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999970e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999978e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999979e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999984e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999986e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999986e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999996e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999996e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |